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   In	  radiation	  therapy	  for	  the	  treatment	  of	  cancer,	  there	  is	  demand	  for	  novel	  
approaches	  that	  will	  improve	  tumor	  cell	  killing	  while	  protecting	  healthy	  tissue.	  One	  such	  
approach	  that	  has	  shown	  considerable	  promise	  is	  the	  application	  of	  nanoparticles	  as	  
radiation	  sensitizers	  for	  tumor	  cells	  and	  as	  radiation	  protectants	  for	  healthy	  tissue.	  In	  this	  
investigation,	  cerium	  oxide	  nanoparticles	  (CNPs)	  obtained	  from	  the	  University	  of	  Central	  
Florida’s	  NanoScience	  Technology	  Center	  were	  studied	  for	  their	  protective	  effect	  to	  
charged	  particle	  radiation	  in	  non-­‐malignant	  breast	  cells,	  and	  for	  their	  sensitizing	  effect	  in	  
breast	  and	  prostate	  cancer	  cell	  lines.	  These	  experiments	  were	  conducted	  at	  East	  Carolina	  
University,	  where	  human	  cells	  were	  grown	  in	  the	  cell	  culture	  facility	  in	  the	  Department	  of	  
Biology	  and	  then	  irradiated	  with	  energetic	  protons	  in	  the	  Accelerator	  Laboratory	  in	  the	  
Department	  of	  Physics.	  Prior	  to	  irradiation,	  the	  cells	  were	  treated	  with	  distinct	  CNP	  
preparations	  ranging	  in	  concentrations	  from	  10	  nanomolar	  to	  10	  micromolar,	  and	  cell	  
viability	  was	  assessed	  using	  multiple	  assays	  post-­‐irradiation.	  Radioprotection	  and	  
radiosensitization	  were	  observed	  for	  several	  of	  the	  CNP	  treatments	  tested.	  Ultimately,	  the	  
goal	  is	  to	  find	  a	  specific	  nanoparticle	  treatment	  that	  holds	  the	  synergistic	  effect	  of	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Chapter	  1:	  Introduction	  
	  
	   Ionizing	  radiation	  is	  a	  valuable	  resource	  for	  humanity	  when	  properly	  controlled	  and	  
is	  widely	  used	  in	  the	  fields	  of	  medicine,	  agriculture,	  energy,	  and	  research.	  It	  is,	  however,	  
harmful	  to	  people	  and	  certainly	  lethal	  at	  sufficiently	  high	  doses.	  It	  has	  a	  damaging	  effect	  on	  
human	  tissue	  that	  can	  disrupt	  the	  normal	  operations	  and	  functions	  of	  cells	  within	  the	  body.	  
The	  potential	  risks	  to	  our	  bodies	  have	  inspired	  research	  focused	  solely	  on	  radiation	  
exposure	  from	  accidents	  like	  industrial	  incidents,	  acts	  of	  terrorism,	  and	  even	  space	  travel	  
[1,	  2].	  Studies	  have	  shown	  that	  radiation	  due	  to	  medical	  sources	  alone	  is	  responsible	  for	  an	  
almost	  600%	  increase	  in	  exposure	  over	  the	  past	  three	  decades,	  primarily	  from	  CT	  scanning	  
and	  nuclear	  medicine	  [3].	  It	  is	  estimated	  that	  medical	  radiation	  exposure	  is	  now	  
approximately	  equal	  to	  natural	  background	  radiation	  [3].	  The	  biological	  effect	  of	  ionizing	  
radiation	  on	  human	  tissue	  is	  primarily	  a	  consequence	  of	  the	  ionization	  of	  the	  atoms	  that	  
make	  up	  the	  molecules	  of	  the	  tissue.	  An	  abundance	  of	  radiation	  exposure	  can	  produce	  
immediate	  effects	  such	  as	  radiation	  sickness	  as	  well	  as	  long-­‐term	  effects	  such	  as	  cancer	  [4].	  
Within	  the	  scope	  of	  radiation	  therapy,	  ionizing	  radiation	  can	  be	  beneficial	  and	  is	  used	  for	  
the	  treatment	  of	  certain	  cancers.	  Efforts	  are	  being	  made	  that	  incorporate	  specialized	  
additives	  as	  a	  way	  to	  enhance	  the	  effectiveness	  of	  this	  therapy	  [5,	  6].	  In	  other	  fields,	  where	  
ionizing	  radiation	  is	  unavoidable	  and	  destructive,	  the	  main	  focus	  is	  to	  lessen	  its	  damaging	  
effects.	  In	  the	  area	  of	  extended	  space	  travel,	  there	  is	  concern	  that	  astronauts	  who	  suffer	  
from	  short-­‐term	  effects	  due	  to	  overexposure	  would	  not	  have	  accessible	  or	  sufficient	  
medical	  care.	  Therefore,	  efforts	  are	  being	  made	  to	  discover	  techniques	  to	  prevent	  or	  
mitigate	  the	  damaging	  effects	  of	  radiation	  [7].	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   Radiation	  describes	  the	  emission	  and	  propagation	  of	  energy	  through	  space	  or	  a	  
material	  medium	  [4].	  As	  radiation	  traverses	  a	  material,	  it	  will	  encounter	  the	  orbital	  
electrons	  and	  atomic	  nuclei	  of	  the	  atoms	  inside	  and	  interact	  via	  elastic	  collisions,	  inelastic	  
collisions,	  or	  absorption	  events.	  Energy	  is	  deposited	  along	  the	  path	  that	  it	  travels	  in	  the	  
material,	  known	  as	  the	  track	  [4].	  The	  amount	  of	  deposited	  energy	  and	  its	  distribution	  
depends	  on	  the	  radiation	  type	  and	  the	  probability	  (cross-­‐section)	  of	  particle	  interactions	  
within	  the	  material.	  The	  atoms	  within	  a	  material	  can	  absorb	  this	  lost	  energy	  through	  
excitation	  or	  ionization,	  decreasing	  the	  intensity	  of	  the	  radiation	  as	  it	  traverses	  the	  
material.	  This	  process	  generates	  secondary	  electrons	  that	  contain	  enough	  energy	  to	  
contribute	  to	  damage	  within	  a	  material.	  These	  unbound	  electrons	  can	  now	  transport	  the	  
energy	  nearby	  or	  deposit	  the	  energy	  far	  away	  from	  its	  original	  position,	  thus	  propagating	  
the	  process.	  The	  dose	  is	  the	  amount	  of	  this	  energy	  absorbed	  in	  the	  material,	  given	  as	  energy	  
per	  unit	  mass	  in	  Gray	  (Gy)	  [4].	  There	  are	  different	  kinds	  of	  radiation	  that	  can	  deposit	  such	  
energy	  including	  high-­‐energy	  photons	  (x-­‐rays	  and	  gamma	  rays),	  electrons,	  neutrons,	  
protons,	  alpha	  particles	  and	  heavier	  ions.	  Each	  class	  of	  radiation	  has	  multiple	  processes	  for	  
interacting	  and	  depositing	  energy	  in	  matter.	  Protons,	  neutrons,	  electrons,	  alpha	  particles	  
and	  heavier	  ions	  are	  characterized	  as	  particulate	  radiation.	  Photons	  fall	  into	  the	  category	  of	  
electromagnetic	  radiation	  and	  will	  primarily	  interact	  with	  matter	  by	  means	  of	  the	  
photoelectric	  effect,	  the	  compton	  effect,	  or	  pair	  production.	  
1.1	  Electromagnetic	  Radiation	  
	   In	  the	  photoelectric	  effect,	  an	  incident	  photon	  is	  completely	  absorbed	  by	  an	  atom.	  
This	  causes	  a	  core	  electron	  to	  be	  ejected	  from	  the	  atom	  leaving	  behind	  a	  vacancy.	  The	  atom	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is	  left	  in	  an	  excited	  state,	  which	  results	  in	  a	  de-­‐excitation	  process	  that	  allows	  an	  outer	  
electron	  to	  fall	  to	  the	  inner	  orbit	  and	  fill	  the	  vacancy.	  Characteristic	  X-­‐rays	  and/or	  Auger	  
electrons	  are	  produced	  as	  a	  result	  of	  this	  transition	  process.	  This	  generally	  occurs	  at	  
energies	  up	  to	  0.5	  Mev	  [8].	  
	   With	  the	  Compton	  effect,	  an	  incident	  photon	  interacts	  with	  an	  outer	  shell	  electron.	  
The	  photon	  strikes	  a	  loosely	  bound	  orbital	  electron	  and	  transfers	  a	  portion	  of	  its	  energy.	  
The	  electron	  ejects,	  and	  the	  photon	  scatters.	  This	  results	  in	  a	  Compton	  electron	  and	  a	  
lower-­‐energy	  scattered	  photon.	  The	  Compton	  effect	  tends	  to	  dominate	  between	  0.5	  Mev	  
and	  5	  Mev	  [8].	  
	   For	  pair	  production	  to	  occur,	  a	  high-­‐energy	  incident	  photon	  with	  sufficient	  
minimum	  energy	  of	  1.022	  MeV	  interacts	  with	  an	  atom’s	  nucleus.	  	  As	  a	  result	  of	  this	  
interaction	  the	  photon	  annihilates	  and	  an	  electron-­‐positron	  pair	  is	  created.	  This	  specific	  
minimum	  energy	  required	  of	  the	  incoming	  photon	  is	  representative	  of	  the	  total	  rest	  mass	  
of	  the	  electron-­‐positron	  pair.	  If	  there	  is	  excess	  energy	  above	  this	  requirement,	  it	  is	  
transferred	  to	  kinetic	  energy	  that	  is	  shared	  by	  the	  pair.	  The	  positron	  will	  eventually	  
interact	  with	  another	  electron	  and	  annihilate.	  This	  annihilation	  produces	  two	  511	  KeV	  
photons	  traveling	  in	  opposite	  directions	  and	  fulfills	  the	  physical	  laws	  of	  conservation	  of	  
momentum	  and	  energy.	  Pair	  production	  will	  start	  to	  dominate	  at	  energies	  above	  5	  MeV	  [8].	  
	   In	  all	  of	  these	  cases	  the	  subsequent	  secondary	  electrons	  and	  photons	  will	  continue	  
to	  interact	  in	  a	  cascading	  manner,	  depositing	  their	  energy	  throughout	  a	  targeted	  material.	  
Neutrons,	  electrons,	  protons,	  and	  heavy	  ions	  are	  considered	  particulate	  radiation,	  and	  they	  
have	  distinct	  processes	  for	  interacting	  with	  matter.	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1.2	  Particulate	  Radiation	  
	   Since	  neutrons	  do	  not	  experience	  a	  Coulomb	  force,	  they	  interact	  with	  matter	  
through	  direct	  head-­‐on	  collisions.	  These	  collisions	  are	  primarily	  with	  atomic	  nuclei	  in	  the	  
target	  material.	  Collisions	  with	  orbital	  electrons	  are	  negligible.	  Neutrons	  can	  interact	  with	  
matter	  through	  neutron	  moderation	  (elastic	  collisions),	  neutron	  resonance	  scattering	  
(inelastic	  collisions),	  or	  through	  nuclear	  reaction	  (an	  absorption	  process)	  [9].	  Since	  they	  
provide	  a	  neutral	  charge	  and	  a	  small	  cross	  sectional	  area	  in	  general	  (except	  with	  resonance	  
scattering),	  neutrons	  have	  no	  definite	  range	  of	  penetration.	  The	  most	  elastic	  collisions	  with	  
atomic	  nuclei	  will	  occur	  with	  those	  that	  are	  light	  in	  mass,	  such	  as	  hydrogen	  nuclei	  which	  is	  
essentially	  a	  proton.	  Having	  close	  to	  the	  same	  mass,	  this	  interaction	  would	  result	  in	  a	  
significant	  loss	  in	  the	  kinetic	  energy	  of	  the	  neutron.	  However,	  with	  heavier	  atomic	  nuclei,	  
only	  a	  small	  fraction	  of	  the	  neutron’s	  energy	  would	  be	  lost	  in	  a	  collision	  and	  thus	  providing	  
the	  neutron	  with	  a	  longer	  range	  in	  the	  target	  medium	  [9,	  10].	  
	   The	  primary	  interaction	  for	  incoming	  electrons	  will	  be	  with	  other	  orbital	  electrons.	  	  
The	  Coulomb	  force	  dictates	  how	  electrons	  will	  interact	  in	  matter.	  For	  high	  electron	  
energies	  (like	  in	  medical	  applications),	  elastic	  and	  nuclear	  interactions	  will	  occur.	  
Rutherford	  scattering	  occurs	  when	  electrons	  undergo	  elastic	  interactions.	  Inelastic	  
collisions,	  such	  as	  electron-­‐nucleus	  Coulomb	  interactions,	  can	  result	  in	  bremsstrahlung	  
radiation,	  which	  occurs	  when	  an	  electron	  emits	  a	  photon	  as	  it	  experiences	  a	  change	  in	  
acceleration.	  This	  difference	  in	  the	  acceleration	  of	  the	  electron	  causes	  a	  change	  in	  kinetic	  
energy	  and	  manufactures	  a	  photon	  with	  that	  same	  energy	  [11].	  The	  bremsstrahlung	  
photons	  may	  then	  go	  on	  to	  have	  secondary	  interactions	  in	  the	  target	  medium.	  Because	  this	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type	  interaction	  contains	  equivalent	  masses,	  large	  losses	  in	  energy	  are	  common.	  Scattering	  
angles	  can	  be	  sufficiently	  wide	  as	  well,	  causing	  the	  ultimate	  path	  inside	  the	  target	  material	  
to	  become	  convoluted.	  For	  lower	  electron	  energies,	  ionizations	  and	  excitations	  will	  
dominate.	  As	  the	  electron	  ionizes	  along	  the	  path	  and	  moves	  to	  the	  end	  of	  its	  range	  in	  the	  
material,	  it	  will	  slow	  down	  and	  deposit	  more	  energy.	  This	  is	  due	  to	  the	  strong	  velocity	  
dependence	  of	  the	  ionization	  cross	  section	  [12].	  Low	  energy	  secondary	  electrons	  will	  eject	  
from	  the	  ionizations	  along	  the	  track	  and	  higher-­‐energy	  secondary	  electrons	  (so	  called	  delta	  
rays)	  can	  eject	  much	  further	  from	  the	  original	  track	  [10].	  
	   Heavier	  charged	  particles	  behave	  in	  a	  similar	  fashion	  as	  electrons	  in	  the	  way	  that	  
they	  are	  dictated	  by	  the	  Coulomb	  force.	  Nuclear	  elastic	  scattering	  may	  occur,	  as	  well	  as	  the	  
expected	  ionizations	  and	  excitations.	  For	  higher	  energies,	  nuclear	  collisions	  will	  typically	  
result	  in	  target	  fragmentation.	  They	  can	  undergo	  elastic	  Rutherford	  scattering	  as	  well	  as	  
inelastic	  interactions	  resulting	  in	  bremsstrahlung	  radiation,	  however	  these	  effects	  are	  
usually	  neglected	  since	  the	  scattering	  angles	  are	  so	  small.	  A	  heavier	  charged	  particle	  will	  
lose	  energy	  in	  matter	  primarily	  through	  ionization	  and	  excitation	  of	  orbital	  electrons.	  This	  
is	  known	  as	  collisional	  energy	  loss.	  Secondary	  electrons	  can	  result	  from	  the	  collisions,	  and	  
these	  ejected	  delta	  rays	  can	  contain	  adequate	  kinetic	  energy	  to	  promote	  further	  ionization	  
in	  the	  target	  matter.	  Unlike	  electrons	  and	  uncharged	  particles,	  heavier	  charged	  particles	  
tend	  to	  have	  a	  straighter	  path	  in	  the	  target	  medium	  due	  to	  their	  heavier	  mass.	  As	  the	  
heavier	  charged	  particles	  travel	  through	  the	  medium	  losing	  energy,	  they	  slow	  down	  and	  
the	  energy	  loss	  spikes	  right	  before	  dropping	  off	  at	  the	  end	  of	  their	  range.	  This	  increase	  in	  
energy	  deposition	  at	  the	  end	  of	  the	  path	  is	  called	  the	  Bragg	  peak	  [9].	  The	  energy	  deposition	  
is	  typically	  shown	  as	  a	  plot	  of	  stopping	  power	  vs.	  range	  in	  the	  target	  material,	  with	  the	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Bragg	  peak	  being	  the	  region	  at	  which	  the	  rate	  of	  energy	  loss	  is	  a	  maximum.	  As	  the	  energy	  of	  
the	  incoming	  particle	  increases,	  the	  Bragg	  peak	  is	  pushed	  further	  into	  the	  medium.	  
1.3	  Types	  of	  Radiation	  Damage	  
	   When	  it	  comes	  to	  biological	  material	  and	  ionizing	  radiation,	  the	  ultimate	  concern	  is	  
DNA	  damage.	  	  With	  direct	  damage,	  charged	  particles	  or	  photons	  alter	  DNA	  directly	  causing	  
strand	  breaks,	  base	  damages,	  etc.	  Indirect	  damage	  occurs	  when	  molecules	  in	  the	  
surrounding	  medium	  (water)	  are	  ionized	  to	  form	  free	  radicals,	  which	  can	  subsequently	  
damage	  nearby	  DNA	  and	  cause	  strand	  breaks.	  The	  exposure	  of	  cells	  to	  radiation	  gives	  rise	  
to	  these	  free	  radicals,	  formed	  from	  ionizing	  reactions,	  which	  in	  turn	  react	  with	  the	  DNA	  
[13].	  When	  it	  comes	  to	  damage	  and	  the	  repair	  process,	  a	  single	  strand	  break	  is	  easier	  for	  
the	  cell	  to	  repair	  than	  a	  double	  strand	  break	  [14].	  A	  double	  strand	  break	  forms	  when	  two	  
single	  strand	  breaks	  occur	  in	  near	  vicinity	  to	  each	  other.	  This	  probability	  increases	  with	  
higher	  linear	  energy	  transfer	  (LET)	  radiation,	  since	  there	  are	  more	  events	  per	  track	  length	  
available.	  Whether	  direct	  or	  indirect,	  these	  kinds	  of	  damages	  can	  lead	  to	  multiple	  endpoints	  
including	  mutations,	  chromosome	  aberrations,	  genomic	  instability,	  or	  ultimately	  apoptosis	  
[15].	  
	   Radioprotectors	  are	  of	  growing	  interest	  as	  a	  way	  to	  mitigate	  damage	  to	  the	  cell	  by	  
removing	  these	  free	  radicals.	  By	  providing	  valence	  electrons,	  radioprotectors	  can	  bind	  with	  
the	  radicals	  and	  neutralize	  them.	  This	  process	  is	  essentially	  intercepting	  free	  radicals	  
before	  they	  have	  a	  chance	  to	  cause	  indirect	  damage	  to	  DNA	  [16].	  It	  would	  be	  exceptionally	  
beneficial	  to	  discover	  an	  alternative	  that	  serves	  as	  both	  an	  effective	  radioprotector	  for	  
normal	  tissue	  and	  an	  effective	  radiosensitizer	  for	  tumor	  tissue	  in	  radiation	  therapy.	  Recent	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studies	  show	  that	  cerium	  oxide	  nanoparticles	  (CeO2)	  are	  being	  tested	  as	  appropriate	  free	  
radical	  scavengers	  and	  show	  potential	  for	  increasing	  cell	  survival	  [17,	  18].	  Although	  some	  
research	  has	  been	  piloted	  using	  photon	  radiation	  (x-­‐rays),	  the	  influence	  that	  cerium	  oxide	  
nanoparticles	  have	  when	  paired	  with	  charged	  particle	  radiation	  remains	  under	  
investigation.	  
1.4	  Radiological	  Physics	  
	   One	  essential	  building	  block	  of	  radiation	  physics,	  and	  by	  extension	  dosimetry,	  is	  the	  
measure	  of	  stopping	  power.	  Stopping	  power	  describes	  the	  average	  linear	  rate	  of	  energy	  
loss	  in	  a	  medium	  by	  a	  charged	  particle	  [10].	  It	  is	  typically	  represented	  as	  -­‐dE/dx	  where	  E	  
symbolizes	  energy	  and	  x	  signifies	  distance,	  giving	  units	  typically	  of	  MeV/cm.	  If	  the	  
probability	  per	  unit	  distance	  of	  travel	  that	  an	  electronic	  collision	  occurs	  is	  denoted	  as	  µ	  and	  
the	  average	  energy	  loss	  per	  collision	  is	  expressed	  as	  Qavg,	  then	  the	  stopping	  power	  can	  be	  
found	  as	  the	  product	  of	  these	  two	  quantities.	  It	  is	  calculated	  as	  
	  
𝑆 𝐸 = −
𝑑𝐸
𝑑𝑥 =   𝜇𝑄!"# = 𝜇 𝑄𝑊 𝑄 𝑑𝑄
!!"#
!!"#
	   (1.1)	  
with	  µ	  (the	  attenuation	  coefficient)	  given	  in	  units	  of	  cm-­‐1	  and	  Qavg	  measured	  in	  eV.	  Qavg	  is	  
equivalent	  to	  the	  integration	  of	  the	  single	  collision	  energy-­‐loss	  spectra,	  where	  Q	  is	  the	  
energy	  loss	  for	  each	  collision	  and	  W(Q)dQ	  is	  the	  probability	  that	  a	  given	  collision	  will	  result	  
in	  an	  energy	  loss	  between	  the	  range	  of	  Q	  and	  Q+dQ.	  
	   It	  can	  be	  useful	  to	  divide	  the	  stopping	  power	  by	  the	  density	  of	  the	  target	  material,	  ρ	  
(g/cm3).	  This	  is	  known	  as	  mass	  stopping	  power	  and	  is	  represented	  as	  –dE/ρdx	  with	  units	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typically	  of	  MeV	  cm2/g,	  and	  this	  conveys	  the	  rate	  of	  energy	  loss	  of	  the	  charged	  particle	  per	  
g	  cm-­‐2	  of	  the	  material	  penetrated.	  This	  way	  of	  expression	  is	  extremely	  beneficial	  since	  the	  
mass	  stopping	  power	  is	  somewhat	  uniform	  among	  materials	  sharing	  similar	  atomic	  
compositions	  [10].	  The	  stopping	  power	  would	  depend	  on	  the	  pressure	  for	  a	  gas	  target.	  
Using	  the	  mass	  stopping	  power	  instead	  rectifies	  this	  issue	  of	  pressure	  dependence	  since	  it	  
is	  already	  taken	  into	  account	  by	  the	  density	  of	  the	  target.	  
	   Although	  the	  stopping	  power	  represents	  the	  amount	  of	  energy	  lost	  by	  a	  particle	  as	  it	  
travels	  through	  a	  material,	  it	  does	  not	  necessarily	  equal	  the	  amount	  of	  energy	  absorbed	  by	  
a	  target.	  This	  is	  especially	  true	  for	  small	  targets	  like	  cells.	  The	  range	  of	  the	  secondary	  
electrons	  produced	  by	  the	  incident	  radiation	  has	  to	  be	  considered.	  The	  higher	  the	  incident	  
radiation	  energy,	  the	  higher	  the	  possible	  maximum	  energy	  transfer	  will	  be	  to	  a	  secondary	  
particle.	  With	  enough	  energy,	  delta	  rays	  can	  certainly	  escape	  a	  small	  volume	  where	  the	  
initial	  charged	  particle	  lost	  its	  energy.	  Therefore	  the	  restricted	  stopping	  power	  is	  a	  better	  
representation	  of	  the	  amount	  of	  lost	  energy	  that	  is	  actually	  absorbed	  in	  the	  target	  [10].	  
Restricted	  stopping	  power,	  -­‐(dE/dx)Δ,	  is	  characterized	  as	  the	  rate	  of	  energy	  loss	  due	  only	  to	  
the	  collisions	  in	  which	  the	  energy	  transfer	  does	  not	  exceed	  a	  determined	  threshold	  Δ.	  It	  is	  
used	  as	  a	  way	  to	  measure	  the	  localized	  energy	  transfer	  along	  the	  track	  and	  excludes	  all	  
secondary	  electrons	  with	  kinetic	  energies	  above	  larger	  than	  Δ.	  Linear	  energy	  transfer	  (LET)	  
was	  introduced	  in	  the	  early	  1950’s	  and	  is	  defined	  as	  the	  rate	  of	  energy	  transferred	  per	  unit	  
distance	  along	  the	  path	  of	  the	  charged	  particle	  with	  units	  of	  keV/μm	  [8].	  LET	  and	  stopping	  
power	  are	  two	  distinctive	  ways	  of	  characterizing	  similar	  settings.	  Stopping	  power	  is	  
portrayed	  in	  terms	  of	  energy	  lost,	  while	  LET	  is	  explained	  in	  terms	  of	  energy	  transferred.	  
Either	  way	  it	  is	  approached,	  both	  terms	  can	  be	  classified	  as	  restricted	  or	  unrestricted.	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   If	  two	  identically	  charged	  particles	  were	  to	  penetrate	  the	  same	  type	  material,	  they	  
would	  not	  necessarily	  behave	  the	  same	  way.	  This	  stochastic	  nature	  causes	  statistical	  
fluctuations	  in	  the	  number	  of	  collisions	  along	  a	  path	  and	  the	  amount	  of	  energy	  lost	  due	  to	  
each	  collision.	  Any	  number	  of	  identical	  particles	  starting	  out	  under	  identical	  conditions	  will	  
result	  in	  a	  distribution	  of	  energies	  as	  they	  pass	  a	  given	  depth	  and	  a	  distribution	  of	  
pathlengths	  traversed	  before	  they	  stop.	  This	  phenomenon	  of	  identical	  initial	  conditions	  
yielding	  unequal	  losses	  in	  energy	  is	  called	  energy	  straggling,	  and	  the	  existence	  of	  varying	  
pathlengths	  is	  referred	  to	  as	  range	  straggling	  [8].	  
	   An	  increase	  in	  the	  energy	  of	  the	  incoming	  charged	  particle	  would	  increase	  its	  
velocity	  and	  ultimately	  cause	  an	  increase	  in	  the	  range	  of	  the	  charged	  particle,	  so	  long	  as	  the	  
ionization	  cross	  section	  did	  not	  increase.	  An	  increase	  in	  energy	  would	  also	  cause	  the	  
stopping	  power	  to	  decrease,	  since	  the	  number	  of	  possible	  interactions	  decreases	  and	  it	  
becomes	  less	  likely	  to	  slow	  down	  the	  particle	  with	  collisions.	  For	  the	  probability	  of	  
interactions	  to	  increase,	  the	  energy	  of	  the	  charged	  particle	  must	  decrease,	  the	  density	  of	  
the	  target	  material	  must	  increase,	  or	  the	  volume	  of	  the	  target	  must	  be	  made	  large	  enough	  
to	  improve	  the	  chance	  of	  collisions	  between	  the	  charged	  particle	  and	  orbital	  electrons.	  On	  a	  
plot	  of	  relative	  count	  rate	  vs.	  absorber	  thickness,	  the	  mean	  range	  can	  be	  found	  as	  the	  
amount	  of	  absorber	  thickness	  required	  to	  obtain	  a	  relative	  count	  rate	  of	  0.5,	  and	  an	  
extrapolated	  range	  can	  be	  found	  by	  extending	  the	  straight	  portion	  of	  the	  curve	  down	  to	  the	  
x-­‐axis	  [10].	  Monte	  Carlo	  simulations	  that	  are	  built	  into	  the	  Stopping	  and	  Range	  of	  Ions	  in	  
Matter	  (SRIM)	  code	  show	  that	  the	  range	  straggling	  difference	  for	  3	  MeV	  protons	  in	  water	  is	  
approximately	  eight	  percent	  [19].	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1.5	  Calculating	  Dose	  
	   For	  radiotherapy	  and	  radiobiological	  experiments,	  it	  is	  essential	  to	  measure	  the	  
dose	  in	  the	  beam	  of	  charged	  particles.	  This	  is	  often	  accomplished	  by	  placing	  ionization	  
chambers	  at	  different	  depths	  within	  the	  target	  material	  while	  exposed	  to	  the	  beam.	  The	  
dose	  rate	  is	  proportional	  to	  the	  current	  of	  the	  beam.	  For	  a	  monoenergetic	  beam,	  a	  depth-­‐
dose	  curve	  shows	  the	  dose	  rate	  as	  having	  a	  maximum	  in	  the	  Bragg	  peak	  region	  near	  the	  
end	  of	  the	  particle’s	  range.	  The	  LET	  would	  also	  reach	  a	  maximum	  at	  that	  same	  depth	  in	  the	  
target	  material.	  For	  a	  beam	  of	  low-­‐energy	  protons	  (≤400	  MeV),	  the	  energy	  lost	  in	  a	  target	  
material	  is	  almost	  entirely	  due	  to	  collisions	  with	  orbital	  electrons.	  For	  a	  beam	  of	  high-­‐
energy	  protons,	  there	  begin	  to	  be	  more	  nuclear	  interactions	  and	  the	  depth-­‐dose	  curves	  can	  
become	  quite	  different	  from	  the	  mass	  stopping	  power	  curves	  [10].	  
	   To	  effectively	  calculate	  a	  dose	  rate,	  a	  uniform	  parallel	  beam	  comprised	  of	  
monoenergetic	  charged	  particles	  is	  considered.	  If	  this	  beam	  is	  normally	  incident	  on	  a	  thick	  
tissue	  slab,	  then	  a	  fluence	  rate	  𝜑	  can	  be	  measured	  in	  cm-­‐2	  s-­‐1.	  	  To	  calculate	  the	  dose	  rate	  at	  a	  
given	  depth	  x	  in	  the	  slab,	  a	  thin	  disc-­‐shaped	  volume	  with	  thickness	  Δx	  is	  considered	  along	  
the	  central	  axis	  having	  an	  area	  A	  normal	  to	  the	  beam.	  Using	  the	  collisional	  stopping	  power	  
(-­‐dE/dx),	  the	  rate	  of	  energy	  deposition	  in	  the	  volume	  can	  then	  be	  calculated	  as	  




where	  𝐸	  is	  measured	  in	  MeV	  s-­‐1	  [10].	  Now	  the	  dose	  rate	  can	  be	  understood	  by	  dividing	  the	  
rate	  of	  energy	  deposition	  by	  the	  mass	  of	  the	  volume	  element	  (ρAΔx)	  to	  get	  








where	  	  ρ	  is	  the	  density	  of	  the	  tissue.	  The	  dose	  rate	  𝐷	  is	  measured	  in	  units	  of	  MeV	  g-­‐1	  s-­‐1	  [10].	  
It	  can	  be	  recognized	  that	  the	  dose	  per	  unit	  fluence	  at	  any	  given	  depth	  is	  equivalent	  to	  the	  
mass	  stopping	  power	  for	  particles	  at	  that	  given	  depth.	  For	  instance,	  if	  the	  mass	  stopping	  
power	  is	  5	  MeV	  cm2	  g-­‐1,	  then	  the	  dose	  per	  unit	  fluence	  can	  be	  written	  as	  5	  MeV	  g-­‐1	  assuming	  
the	  fluence	  unit	  is	  in	  cm-­‐2.	  For	  high-­‐energy	  charged	  particles,	  this	  analysis	  becomes	  
insufficient	  as	  the	  nuclear	  interactions	  become	  more	  significant	  and	  the	  depth-­‐dose	  curves	  
cannot	  be	  accurately	  calculated.	  At	  that	  point	  Monte	  Carlo	  calculations	  are	  considered	  that	  
estimate	  the	  outcome	  of	  individual	  incident	  and	  secondary	  particles	  statistically	  using	  the	  
cross	  sections	  of	  various	  nuclear	  interactions	  that	  transpire.	  Since	  the	  energies	  used	  in	  this	  
research	  were	  low	  (<4	  MeV),	  Monte	  Carlo	  simulations	  were	  not	  required	  and	  this	  analysis	  
was	  adequate	  in	  determining	  the	  dose	  rate.	  
1.6	  Water-­‐Derived	  Radicals	  	  
	   Ionizing	  radiation	  can	  produce	  an	  abundance	  of	  secondary	  electrons	  in	  matter,	  and	  
even	  more	  so	  in	  liquid	  water.	  This	  is	  especially	  relevant	  in	  understanding	  the	  biological	  
effect	  to	  mammalian	  cells,	  which	  are	  comprised	  of	  approximately	  70-­‐85%	  water.	  These	  
secondary	  electrons	  deposit	  their	  kinetic	  energy	  throughout	  the	  water	  volume	  [9].	  In	  the	  
first	  10-­‐15	  seconds	  of	  radiation,	  the	  initial	  changes	  in	  water	  result	  in	  the	  creation	  of	  ionized	  
molecules	  (H2O+),	  excited	  molecules	  (H2O*),	  and	  free	  electrons	  (e-­‐)	  in	  local	  regions	  around	  
the	  track	  [10].	  These	  three	  species	  generate	  changes	  in	  the	  water	  volume	  that	  produce	  free	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radicals.	  There	  are	  numerous	  reactions	  and	  various	  products	  that	  arise	  from	  the	  radiolysis	  
of	  water	  within	  a	  cell,	  as	  seen	  in	  the	  literature	  [20-­‐23].	  One	  possibility	  is	  for	  an	  ionized	  
water	  molecule	  to	  react	  with	  a	  neighboring	  molecule	  to	  form	  a	  hydronium	  ion	  and	  a	  
hydroxyl	  radical.	  
	     𝐻!𝑂! + 𝐻!𝑂 → 𝐻!𝑂! + 𝑂𝐻 	   (1.4)	  
Another	  possibility	  is	  for	  an	  excited	  water	  molecule	  to	  give	  up	  its	  energy	  either	  by	  losing	  an	  
electron	  (thus	  becoming	  an	  ion)	  or	  by	  molecular	  dissociation.	  
	     𝐻!𝑂∗ →
𝐻!𝑂! + 𝑒!
𝐻 + 𝑂𝐻
	   (1.5)	  
The	  free	  electrons	  can	  become	  thermalized	  by	  losing	  their	  energy	  to	  water	  molecules	  
through	  vibrational	  and	  rotational	  excitation	  [10].	  These	  thermalized	  electrons	  orient	  the	  
permanent	  dipole	  moments	  of	  neighboring	  water	  molecules	  forming	  a	  cluster	  or	  aqueous	  
electron.	  
	     𝑒! → 𝑒!"! 	   (1.6)	  
	   Of	  the	  new	  reactants	  that	  were	  formed,	  OH,	  𝑒!"! ,	  and	  H	  are	  chemically	  reactive.	  
These	  radical	  species	  born	  from	  water	  with	  their	  unpaired	  electrons	  are	  known	  as	  free	  
radicals	  and	  they	  are	  more	  than	  capable	  of	  causing	  biological	  damage.	  With	  cells	  comprised	  
of	  80%	  water,	  free	  radicals	  are	  known	  to	  wreak	  havoc	  to	  DNA	  in	  mammalian	  targets.	  This	  
process	  can	  also	  include	  oxidation	  and	  spawn	  oxygen-­‐derived	  radicals	  known	  as	  reactive	  
oxygen	  species	  (ROS),	  which	  are	  highly	  reactive	  to	  DNA	  [24].	  In	  the	  case	  of	  low	  LET	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radiation	  (such	  as	  <2	  keV/μm	  x-­‐rays	  or	  gamma	  rays),	  free	  radicals	  are	  responsible	  for	  as	  
much	  as	  two	  thirds	  of	  the	  DNA	  damage	  incurred	  [24].	  
1.7	  DNA	  Damage	  and	  Repair	  
	   When	  it	  comes	  to	  radiation	  on	  biological	  targets,	  there	  are	  two	  pathways	  for	  
damage:	  direct	  and	  indirect	  [4].	  Direct	  damage	  is	  when	  the	  radiation	  itself	  directly	  interacts	  
with	  the	  cell	  components.	  Indirect	  damage	  is	  when	  free	  radicals	  that	  were	  formed	  from	  the	  
incident	  radiation	  interacting	  inside	  the	  biological	  material	  start	  to	  chemically	  react	  with	  
the	  DNA.	  In	  proton	  radiation,	  for	  example,	  ions	  can	  physically	  break	  base	  pairs	  in	  the	  DNA	  
strands	  by	  means	  of	  direct	  damage.	  That	  same	  radiation	  could	  also	  produce	  an	  OH	  radical	  
that	  may	  attack	  a	  DNA	  sugar	  and	  cause	  a	  strand	  break	  through	  means	  of	  indirect	  damage.	  
Regardless	  of	  the	  pathway,	  the	  damage	  to	  DNA	  from	  direct	  and	  indirect	  effects	  is	  the	  same.	  
There	  can	  be	  basic	  damage	  such	  as	  base	  damages,	  single	  strand	  breaks	  (SSB),	  and	  double	  
strand	  breaks	  (DSB),	  as	  well	  as	  complex	  damage	  that	  includes	  any	  combination	  of	  those.	  
These	  damages	  can	  contribute	  to	  changes	  in	  the	  DNA	  structure	  by	  point	  mutations,	  
chromosome	  aberrations,	  and	  crosslinks	  between	  strands.	  Since	  the	  double-­‐stranded	  
nature	  of	  DNA	  allows	  the	  two	  strands	  to	  complement	  each	  other,	  if	  one	  strand	  is	  broken	  
then	  the	  opposite	  strand	  can	  be	  used	  as	  a	  template	  for	  repair.	  For	  this	  reason,	  most	  single-­‐
strand	  breaks	  can	  be	  repaired	  naturally.	  However,	  with	  double-­‐strand	  breaks,	  repair	  can	  be	  
far	  more	  problematic.	  The	  broken	  ends	  of	  DNA	  may	  be	  incorrectly	  rejoined.	  If	  these	  
occurrences	  are	  not	  properly	  repaired,	  it	  can	  lead	  to	  cell	  damage	  and	  ultimately	  apoptosis	  
(programmed	  cell	  death)	  or	  necrosis	  (death	  due	  to	  injury)	  [24].	  In	  the	  case	  of	  high	  LET	  
radiation	  (>	  4	  keV/μm	  protons,	  neutrons,	  and	  heavy	  ions),	  contributions	  from	  direct	  effects	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become	  dominate,	  and	  repair	  could	  become	  exceedingly	  difficult	  as	  the	  probability	  of	  the	  
complexity	  of	  damage	  increases	  [24].	  Double	  strand	  breaks	  can	  arise	  from	  an	  individual	  
radiation	  track	  alone	  or	  from	  multiple	  single	  strand	  breaks	  within	  close	  proximity,	  for	  
example	  6-­‐10	  base	  pairs	  [25].	  Cells	  that	  survive	  irradiation	  and	  have	  sustained	  a	  double-­‐
strand	  break	  could	  have	  a	  segment	  of	  DNA	  that	  has	  been	  deleted.	  If	  two	  distinct	  double-­‐
strand	  breaks	  occur,	  there	  can	  be	  misrepair	  of	  the	  two	  outer	  ends	  of	  each	  break	  and	  loss	  of	  
the	  section	  between	  the	  breaks.	  There	  is	  also	  the	  possibility	  of	  enzyme	  digestion	  of	  
nucleotides.	  This	  process	  of	  cleaning	  the	  broken	  ends	  of	  one	  double-­‐strand	  break	  before	  
rejoining	  can	  leave	  a	  segment	  deleted	  [24].	  	  
	   Ultimately,	  there	  are	  four	  generalized	  outcomes	  for	  radiation	  damage	  on	  a	  cell	  that	  
can	  occur.	  The	  cell	  can	  go	  undamaged	  from	  the	  radiation	  and	  function	  as	  usual.	  The	  cell	  
could	  incur	  damage,	  but	  the	  damage	  is	  repaired	  properly	  and	  the	  transformed	  cell	  operates	  
normally.	  The	  cell	  could	  receive	  some	  damage	  and	  the	  damage	  is	  misrepaired	  causing	  the	  
cell	  to	  operate	  abnormally.	  The	  cell	  can	  obtain	  sufficient	  damage	  and	  die	  as	  a	  result.	  There	  
are	  many	  different	  types	  of	  cells	  however,	  and	  they	  are	  not	  all	  as	  equally	  sensitive	  to	  
radiation	  damage.	  The	  human	  body	  is	  a	  sophisticated	  interconnected	  system	  with	  various	  
complex	  organs	  and	  certain	  specialized	  cells	  are	  associated	  with	  each	  organ.	  Cells	  that	  are	  
not	  as	  specialized	  and	  divide	  rapidly	  tend	  to	  be	  more	  sensitive	  to	  lower	  doses	  of	  radiation	  
than	  those	  that	  divide	  less	  rapidly	  and	  are	  more	  specialized	  [4].	  
1.8	  Biological	  Effects	  
	   The	  biological	  effect	  of	  radiation	  has	  a	  great	  dependency	  on	  the	  dose	  received,	  the	  
kind	  of	  radiation,	  and	  the	  observed	  endpoint.	  Sometimes	  the	  biological	  effect	  is	  immediate	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and	  other	  times	  it	  may	  take	  years	  for	  it	  to	  become	  evident.	  Two	  categories	  are	  used	  to	  
divide	  up	  these	  effects,	  stochastic	  and	  deterministic	  (or	  nonstochastic)	  [10].	  A	  stochastic	  
event	  is	  one	  that	  will	  occur	  in	  a	  statistical	  manner.	  There	  is	  no	  guarantee	  that	  a	  certain	  
effect	  will	  appear,	  like	  with	  cancer.	  For	  instance,	  if	  a	  large	  population	  of	  people	  were	  to	  be	  
exposed	  to	  radiation,	  it	  is	  possible	  that	  they	  may	  not	  all	  develop	  cancer	  in	  their	  lifetime.	  
Furthermore,	  cancer	  can	  manifest	  naturally	  on	  its	  own	  without	  exposure,	  so	  it	  cannot	  be	  
evident	  that	  any	  radiation	  exposure	  is	  the	  source	  an	  incidence	  of	  cancer.	  What	  is	  
recognized	  is	  that	  the	  chances	  of	  cancer	  increase	  as	  the	  dose	  of	  radiation	  exposure	  
increases.	  Additionally,	  there	  is	  no	  threshold	  dose	  under	  which	  there	  exists	  a	  zero	  
probability	  of	  developing	  cancer.	  Biological	  effects	  of	  ionizing	  radiation	  that	  are	  stochastic	  
include	  a	  shortened	  lifespan,	  genetic	  effects,	  and	  mutated	  offspring.	  On	  the	  other	  hand	  
deterministic	  effects	  have	  a	  more	  clear	  and	  causal	  outcome	  with	  a	  dose	  of	  radiation	  
exposure	  as	  well	  as	  a	  threshold	  dose	  [10].	  Biological	  effects	  of	  ionizing	  radiation	  that	  are	  
deterministic	  include	  cataracts,	  skin	  erythema,	  infertility,	  and	  acute	  radiation	  syndrome	  
(ACR)	  [10].	  If	  a	  person	  is	  exposed	  to	  a	  large	  enough	  short-­‐term	  whole	  body	  dose	  of	  
radiation,	  they	  can	  develop	  ACR.	  This	  results	  in	  the	  rapid	  depletion	  of	  radiosensitive	  cells	  in	  
the	  blood	  and	  digestive	  tract,	  which	  can	  cause	  infection,	  bone	  marrow	  damage,	  organ	  and	  
tissue	  damage,	  and	  even	  death	  at	  high	  enough	  doses.	  
1.9	  Radioprotectors,	  Radiomitigators,	  Radiosensitizers	  
	   There	  are	  certain	  safety	  procedures	  that	  will	  reduce	  or	  even	  prevent	  such	  biological	  
events	  from	  manifesting.	  These	  procedures	  include	  some	  form	  of	  shielding,	  increasing	  the	  
distance	  between	  the	  source	  and	  the	  subject,	  and	  decreasing	  the	  time	  of	  exposure.	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However,	  circumstances	  do	  arise	  in	  which	  a	  subject	  cannot	  implement	  these	  safety	  
procedures.	  In	  those	  situations,	  it	  may	  be	  necessary	  to	  use	  radioprotectors	  to	  reduce	  or	  
mitigate	  the	  damaging	  effects	  of	  ionizing	  radiation.	  The	  ideal	  radioprotector	  would	  contain	  
certain	  uncompromised	  qualities.	  It	  would	  obviously	  have	  to	  significantly	  protect	  against	  
radiation	  effects	  as	  well	  as	  provide	  this	  protective	  effect	  to	  the	  majority	  of	  internal	  organs.	  
At	  the	  same	  time	  it	  must	  have	  an	  efficient	  time-­‐window	  effect,	  an	  acceptable	  toxicity	  and	  
stability	  profile,	  an	  acceptable	  method	  of	  administration,	  and	  be	  compatible	  with	  the	  
expansive	  scope	  of	  other	  drugs	  available	  to	  patients	  and	  workers	  [2].	  There	  are	  currently	  
no	  radioprotectors	  that	  meet	  all	  of	  these	  requirements,	  but	  there	  are	  those	  that	  provide	  
some	  protection	  from	  radiation	  by	  ways	  of	  diminishing	  the	  indirect	  damage	  [26].	  A	  
parameter	  used	  to	  describe	  the	  effectiveness	  of	  a	  radioprotector	  is	  the	  dose	  reduction	  
factor	  (DRF).	  DRF	  is	  determined	  by	  dividing	  the	  dose	  of	  radiation	  in	  the	  presence	  of	  a	  drug	  
at	  a	  set	  lethality	  by	  the	  dose	  of	  radiation	  in	  the	  absence	  of	  the	  drug	  at	  that	  same	  lethality.	  
The	  typical	  lethality	  used	  is	  a	  lethal	  dose	  to	  50	  percent	  of	  the	  population	  after	  30	  days	  (LD	  
50/30)	  [24].	  
	   Currently,	  amifostine	  is	  the	  most	  well	  known	  radioprotector.	  It’s	  active	  molecule	  
WR-­‐1065	  provides	  radioprotection	  to	  cells	  and	  has	  been	  shown	  to	  prevent	  cell	  death	  in	  the	  
presence	  of	  both	  direct	  and	  indirect	  ionizing	  radiation,	  while	  also	  mitigating	  genomic	  
instability	  effects	  in	  the	  surviving	  cells	  [27,	  28].	  Amifostine	  also	  allows	  for	  the	  binding	  of	  
free	  radicals	  and	  can	  induce	  hypoxia,	  which	  prevents	  reactive	  oxide	  radicals	  from	  forming,	  
contributing	  to	  DNA	  protection	  and	  repair	  [29,	  30].	  Because	  of	  its	  success,	  amifostine	  is	  
used	  in	  industry,	  medical	  and	  government	  applications.	  Astronauts	  have	  used	  it	  on	  
missions	  to	  the	  moon	  as	  a	  safety	  precaution	  in	  case	  of	  a	  solar	  event.	  Approved	  by	  the	  Food	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and	  Drug	  Administration	  as	  a	  radioprotector,	  it	  is	  the	  prevailing	  cytoprotective	  compound	  
used	  today	  [24,	  27].	  However,	  amifostine	  is	  not	  the	  ideal	  radioprotector.	  Its	  side	  effects	  
include	  severe	  nausea,	  vomiting,	  allergic	  reactions,	  and	  acute	  hypertension	  [31].	  It	  leaves	  
the	  central	  nervous	  system	  completely	  unprotected,	  so	  it	  is	  unable	  to	  provide	  protection	  to	  
all	  the	  human	  organ	  systems	  [27].	  It	  must	  be	  administered	  before	  exposure,	  which	  is	  not	  a	  
beneficial	  time-­‐window	  effect	  in	  the	  case	  of	  a	  nuclear	  incident	  or	  terrorist	  attack.	  
Amifostine	  is	  valuable	  in	  specific	  scenarios,	  nevertheless	  it	  is	  still	  necessary	  find	  other	  
possible	  radioprotective	  candidates	  that	  can	  more	  adequately	  fulfill	  the	  requirements	  of	  an	  
ideal	  radioprotector.	  
	   Other	  candidates	  include	  radiomitigators,	  nitroxides,	  and	  bisbenzimidazol	  
compounds.	  Palifermin	  is	  a	  considered	  a	  mitagant	  prototype	  and	  is	  delivered	  after	  
exposure	  to	  radiation	  to	  target	  the	  initiated	  cell	  repair	  responses	  that	  include	  DNA	  repair,	  
apoptosis	  activation,	  cell	  proliferation,	  and	  cell	  immunoinflammmatory	  reactions	  [30].	  
Nitroxides	  like	  tempol	  act	  as	  stable	  free	  radical	  compounds	  that	  interact	  with	  other	  free	  
radicals	  that	  develop	  from	  ionizing	  radiation.	  Tempol	  has	  shown	  protective	  properties	  
against	  radiation	  in	  vitro	  for	  mammalian	  cells	  in	  aerobic	  conditions	  as	  well	  as	  in	  vivo	  after	  
whole	  body	  irradiation	  [32,	  33].	  Bisbenzimidazol	  compounds	  also	  show	  promise	  as	  
radioprotectors.	  Hoechst	  3342	  was	  used	  in	  vivo	  and	  showed	  protection	  in	  the	  mouse	  lung	  
model	  when	  administered	  half	  an	  hour	  before	  exposure.	  Higher	  concentrations	  of	  Hoechst	  
3342	  show	  cytotoxicity	  and	  mutagenic	  effects,	  therefore	  derivatives	  of	  Hoechst	  are	  being	  
explored	  that	  will	  produce	  less	  of	  a	  negative	  effect	  [34,	  35].	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   Cytokines	  have	  shown	  potential	  as	  a	  viable	  natural	  radioprotector	  [36].	  Herbal	  
medicines	  and	  antioxidants	  have	  also	  shown	  promise	  in	  providing	  radioprotection.	  
Naturally	  occurring	  vitamin	  E	  is	  a	  free	  radical	  scavenger	  that	  has	  low	  toxicity	  even	  at	  high	  
doses	  and	  shows	  improvement	  of	  survival	  rates	  in	  mice	  exposed	  to	  radiation	  [37,	  38].	  
Melatonin	  is	  a	  naturally	  occurring	  hormone	  produced	  in	  the	  pineal	  gland	  that	  is	  used	  as	  an	  
over-­‐the-­‐counter	  (OTC)	  sleep	  aid.	  Some	  findings	  suggest	  that	  it	  is	  capable	  of	  scavenging	  
free	  radicals	  [39].	  Ginseng	  is	  a	  well-­‐known	  OTC	  herbal	  medicine	  recognized	  for	  its	  benefits	  
with	  diabetes,	  improving	  aging,	  reducing	  stress	  and	  fatigue,	  and	  also	  promoting	  DNA,	  RNA,	  
and	  protein	  synthesis	  [40-­‐42].	  Ginseng	  extract	  was	  used	  with	  human	  lymphocytes	  exposed	  
to	  radiation	  and	  showed	  a	  reduction	  in	  micronuclei,	  which	  is	  an	  indicator	  of	  cellular	  DNA	  
damage	  [43].	  
	   Soy	  products	  are	  also	  promising	  in	  the	  field	  of	  natural	  radioprotectors.	  Genistein	  is	  a	  
naturally	  occurring	  compound	  in	  soybeans	  that	  has	  shown	  benefits	  in	  cardiovascular	  
disease,	  high	  cholesterol	  and	  osteoporosis	  [44].	  The	  protective	  properties	  of	  genistein	  were	  
shown	  in	  a	  study	  where	  it	  was	  intravenously	  injected	  into	  mice	  24	  hours	  prior	  to	  gamma	  
radiation	  exposure	  and	  an	  increase	  in	  survival	  rate	  was	  observed	  [45].	  Genistein	  has	  also	  
shown	  properties	  of	  radiosensitization	  with	  regards	  to	  tumor	  cells,	  specifically	  human	  
cervical	  cancer	  cells	  [46].	  The	  ability	  of	  genistein	  to	  inhibit	  growth	  in	  different	  cell	  lines	  and	  
reduce	  viability	  has	  an	  enhanced	  effect	  when	  combined	  with	  radiation	  [47].	  This	  growth	  
inhibition	  effect	  of	  genistein	  is	  seen	  at	  concentrations	  greater	  than	  10	  μM,	  while	  below	  this	  
concentration	  genistein	  stimulates	  growth.	  An	  analysis	  of	  the	  different	  doses	  of	  genistein	  
(10	  nM	  to	  100	  μM)	  on	  human	  breast	  cancer	  carcinoma	  cells	  revealed	  that	  the	  lower	  doses	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(<	  10	  μM)	  show	  growth	  promotion	  and	  growth	  inhibition	  wasn’t	  displayed	  until	  higher	  
doses	  [48].	  	  
	   Nanotechnology	  has	  become	  increasingly	  popular	  within	  the	  broad	  scope	  of	  
biomedical	  research.	  This	  technology	  has	  applications	  in	  drug	  delivery	  systems,	  tissue	  
engineering,	  luminescent	  biomarkers,	  MRI	  shielding,	  cancer	  therapy,	  as	  well	  as	  many	  
others	  [49].	  There	  have	  been	  developments	  for	  using	  nanoparticles	  in	  radiotherapy	  [5,	  6].	  
Several	  different	  forms	  and	  variations	  of	  nanoparticles	  are	  being	  explored.	  Extensive	  
research	  has	  been	  done	  using	  gold	  [50-­‐55],	  silver	  and	  zinc	  nanoparticles	  [56-­‐59],	  for	  
protection	  from	  or	  sensitization	  to	  radiation.	  There	  are	  promising	  results	  that	  have	  been	  
shown	  for	  a	  wide	  range	  of	  metal-­‐based	  nanoparticles	  in	  the	  field	  of	  radiation	  therapy,	  
including	  platinum,	  iron,	  and	  gadolinium	  [60-­‐63].	  The	  use	  of	  nanoparticles	  in	  radiotherapy	  
is	  an	  active	  area	  of	  research.	  	  
1.10	  Cerium	  Oxide	  Nanoparticles	  
	   Cerium	  oxide	  nanoparticles	  (CNPs)	  have	  been	  shown	  to	  provide	  radioprotection	  to	  
normal	  tissue	  and	  radiosensitization	  to	  malignant	  cells	  using	  x-­‐rays	  [17,	  64-­‐67].	  They	  are	  
comprised	  of	  a	  cerium	  core	  surrounded	  by	  an	  oxygen	  lattice.	  CNPs	  are	  synthesized	  using	  a	  
micro-­‐emulsion	  process	  consisting	  of	  surfactant	  sodium	  bis(2-­‐ethylhexyl)	  sulfosuccinate	  
(AOT),	  toluene,	  and	  water	  [18].	  CNPs	  have	  gained	  a	  lot	  of	  interest	  due	  to	  their	  regenerative	  
antioxidant	  properties	  exhibited	  in	  the	  reaction	  cycle	  of	  Ce3+	  to	  Ce4+	  to	  Ce3+.	  This	  
continuation	  on	  the	  surface	  of	  the	  CNPs	  offers	  an	  antioxidant	  with	  unique	  protection	  
properties	  [65,	  68].	  Cerium	  oxide	  can	  be	  designed	  to	  retain	  a	  specific	  Ce3+/	  Ce4+	  ratio.	  When	  
this	  ratio	  is	  controlled,	  it	  can	  determine	  the	  CNPs	  distinction	  as	  an	  effective	  catalase	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mimetic,	  superoxide	  dismutase	  (SOD)	  mimetic,	  or	  both,	  cleaving	  O2	  radicals	  and	  hydrogen	  
peroxide	  and	  rendering	  them	  inactive	  [66,	  69,	  70].	  Among	  their	  antioxidant	  behaviors,	  
CNPs	  have	  been	  shown	  to	  be	  efficient	  scavengers	  for	  nitric	  oxide	  [71]	  and	  hydroxyl	  radicals	  
[72].	  CNPs	  have	  also	  shown	  oxidant	  properties	  under	  specific	  environmental	  conditions	  
[73].	  These	  properties	  increase	  the	  specialty	  of	  CNPs	  and	  the	  benefits	  of	  their	  effects	  on	  
both	  nonmalignant	  and	  malignant	  cells.	  In	  cancer	  cells,	  CNPs	  have	  been	  shown	  to	  possess	  
an	  inherent	  cytotoxicity	  and	  have	  also	  been	  shown	  to	  sensitize	  tumor	  cells	  to	  radiation-­‐
induced	  apoptosis	  while	  protecting	  the	  surrounding	  healthy	  tissue	  [17,	  18,	  74-­‐76].	  This	  
inherent	  cytotoxicity	  to	  tumor	  cells	  is	  not	  fully	  understood,	  but	  it	  is	  thought	  to	  be	  due	  to	  the	  
CNPs	  ability	  to	  provide	  free	  radicals	  that	  increase	  oxidative	  stress	  to	  the	  cancer	  cells.	  In	  
addition	  to	  the	  cytotoxicity	  trait,	  they	  have	  been	  shown	  to	  limit	  the	  invasive	  characteristics	  
of	  tumor	  cells.	  CNPs	  have	  been	  shown	  to	  decrease	  the	  ability	  of	  myofibroblasts	  to	  stimulate	  
invasion	  by	  squamous	  tumor	  cells	  and	  also	  inhibit	  the	  ability	  of	  squamous	  tumor	  cells	  to	  
invade	  without	  the	  presence	  of	  myofibroblasts	  stimulation	  [77,	  78].	  
	   As	  an	  ideal	  candidate	  for	  radiation	  therapy,	  CNPs	  offer	  the	  synergistic	  feature	  of	  
operating	  as	  an	  oxidant	  for	  cancerous	  cells	  as	  well	  as	  an	  antioxidant	  for	  normal	  cells.	  
Natural	  antioxidants	  have	  the	  potential	  to	  be	  dangerous	  to	  cancer	  patients	  that	  are	  
currently	  receiving	  treatment	  [79].	  This	  provides	  a	  greater	  demand	  for	  an	  appropriate	  
alternative.	  Recent	  studies	  indicate	  that	  treatment	  of	  CNPs	  preceding	  radiation	  therapy	  
leads	  to	  decreased	  cell	  damage	  and	  death	  for	  normal	  tissue	  in	  the	  gastrointestinal	  (GI)	  
tract,	  lung,	  head,	  and	  neck	  [18,	  67,	  74].	  Also,	  CNPs	  have	  the	  ability	  to	  enhance	  the	  killing	  of	  
tumor	  cells	  when	  they	  are	  used	  in	  low	  pH	  conditions	  prior	  to	  radiation	  therapy.	  Studies	  
have	  shown,	  in	  pancreatic	  cancer	  cells,	  that	  CNPs	  have	  the	  ability	  to	  increase	  the	  level	  of	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radiation-­‐induced	  oxidative	  species	  [64].	  Therefore,	  CNPs	  behave	  as	  a	  radiosensitizer	  in	  
cancer	  cells	  by	  encouraging	  the	  production	  of	  reactive	  oxygen	  species	  (ROS)	  and	  
maintaining	  their	  levels	  within	  tumor	  cells.	  This	  behavior	  combined	  with	  their	  inherent	  
toxic	  effects	  make	  CNPs	  a	  formidable	  option	  to	  consider	  when	  combating	  tumor	  cell	  
viability	  and	  growth.	  
	   CNPs	  have	  useful	  applications	  in	  more	  areas	  than	  just	  cancer	  treatment.	  They	  show	  
promise	  in	  treating	  other	  diseases	  as	  well,	  specifically	  those	  characterized	  by	  ROS	  
accumulation.	  Neurodegenerative	  diseases	  such	  as	  Parkinson’s,	  Huntington’s	  Alzheimer’s,	  
and	  age	  related	  macular	  degeneration	  have	  been	  connected	  to	  increased	  ROS	  levels	  which	  
can	  prevent	  cellular	  mechanisms	  from	  combating	  oxidative	  stress	  [80].	  A	  preliminary	  study	  
showed	  that,	  in	  mouse	  models	  of	  hereditary	  retinal	  degeneration,	  CNPs	  scavenged	  ROS	  and	  
reduced	  apoptosis	  in	  photoreceptor	  cells	  preventing	  retinal	  deterioration	  [81].	  The	  
regression	  of	  pre-­‐existing	  pathologic	  retinal	  neovasculature	  has	  also	  been	  demonstrated	  
using	  CNPs,	  which	  suggests	  an	  antiangiogenic	  property	  [80].	  Increased	  ROS	  levels	  have	  
been	  recognized	  as	  an	  important	  influence	  in	  the	  progression	  of	  diabetes.	  These	  levels	  are	  
especially	  high	  in	  the	  liver	  where	  free	  radicals	  are	  removed	  from	  the	  bloodstream	  [82].	  
Studies	  have	  shown	  that,	  once	  treated	  with	  CNPs,	  hepatic	  ROS	  levels	  in	  diabetic	  rats	  
returned	  to	  levels	  that	  were	  similar	  to	  non-­‐diabetic	  rats	  while	  triglycerides	  decreased	  and	  
HDL	  levels	  increased	  in	  the	  blood	  [82].	  In	  pancreatic	  islet	  cells,	  CNPs	  have	  been	  shown	  to	  
increase	  the	  viability	  of	  the	  pancreatic	  islet	  function	  thereby	  increasing	  insulin	  secretion	  
and	  decreasing	  ROS	  levels	  [83].	  These	  results	  help	  to	  further	  support	  CNPs	  as	  a	  possible	  
treatment	  for	  diabetes.	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   Studies	  that	  were	  performed	  with	  CNPs	  in	  animal	  models	  demonstrate	  an	  apparent	  
lack	  of	  toxicity,	  however	  research	  with	  cells	  in	  vitro	  presents	  conflicting	  evidence.	  This	  
conflict	  is	  believed	  to	  arise	  from	  the	  undetermined	  cellular	  and	  environmental	  factors	  that	  
influence	  their	  oxidant	  and	  antioxidant	  behavior	  [84].	  Studies	  have	  shown	  that	  in	  culture	  
CNPs	  are	  toxic	  to	  bronchial	  epithelial	  lung	  fibroblasts	  [85],	  yet	  non-­‐toxic	  to	  mammary	  
epithelial	  cells	  [17],	  pancreatic	  cells	  [64],	  macrophages	  [86],	  and	  keratinocytes	  [87].	  In	  
normal	  cells,	  the	  pH	  level	  of	  the	  cellular	  environment	  enables	  the	  CNPs	  to	  perform	  radical	  
scavenging.	  Research	  on	  numerous	  human	  cancer	  cells	  in	  vitro	  show	  that	  CNPs	  are	  toxic,	  
including	  alveolar	  epithelial	  cancer	  cells	  [76],	  squamous	  cell	  carcinoma	  [77],	  and	  
pancreatic	  carcinomas	  [64].	  They	  have	  been	  shown	  to	  be	  toxic	  to	  pancreatic	  tumors	  in	  vivo	  
as	  well,	  shrinking	  the	  volume	  of	  a	  tumor	  by	  nearly	  40%	  in	  one	  study	  [64].	  This	  cytotoxicity	  
is	  attributed	  to	  the	  CNPs	  ability	  to	  increase	  ROS	  levels	  and	  maintain	  them	  within	  the	  tumor	  
cells.	  Even	  though	  there	  is	  conflicting	  evidence	  between	  the	  effect	  CNPs	  have	  in	  vitro	  and	  
the	  toxicity	  results	  seen	  in	  vivo,	  their	  unique	  manner	  in	  the	  way	  they	  behave	  as	  an	  oxidant	  
for	  tumor	  cells	  and	  as	  an	  antioxidant	  for	  normal	  cells	  establishes	  the	  need	  for	  further	  
investigations	  of	  CNPs	  in	  research.	  Many	  radioprotectors	  are	  described	  by	  one	  antioxidant	  
scavenger	  for	  every	  radical	  that’s	  available	  to	  be	  scavenged.	  A	  single	  CNP,	  on	  the	  other	  
hand,	  can	  scavenge	  multiple	  free	  radicals	  (or	  induce	  oxidation	  of	  multiple	  targets)	  because	  
of	  its	  auto-­‐regenerative	  capability.	  Also,	  with	  their	  regenerative	  antioxidant	  properties,	  
CNPs	  would	  prevent	  the	  need	  for	  multiple	  treatments	  [81].	  Ultimately,	  cerium	  oxide	  
nanoparticles	  hold	  considerable	  potential	  for	  the	  possible	  applications	  within	  biomedical	  
research.	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1.11	  Specific	  Aims	  
 Within	  the	  scope	  of	  radiation	  therapy,	  there	  is	  demand	  for	  a	  novel	  approach	  that	  
will	  improve	  tumor	  cell	  killing	  and	  protect	  normal	  cells	  while	  reducing	  negative	  side	  
effects.	  Recently,	  there	  has	  been	  considerable	  attention	  given	  to	  nanoparticles	  due	  to	  their	  
use	  in	  cancer	  therapy.	  Studies	  reveal	  that	  certain	  metal	  oxide	  nanoparticles	  can	  induce	  
cytotoxicity	  in	  cancer	  cells,	  but	  not	  in	  normal	  cells	  [88].	  Also,	  an	  effective	  radioprotector	  is	  
essential	  for	  the	  future	  of	  space	  travel	  to	  protect	  astronauts	  from	  the	  tremendous	  amount	  
of	  radiation	  accompanied	  by	  deep	  space	  missions	  [89].	  Cerium	  oxide	  nanoparticles	  (CNPs)	  
could	  be	  a	  promising	  candidate	  to	  meet	  the	  current	  needs	  in	  these	  fields.	  It	  is	  the	  basic	  goal	  
of	  this	  investigation	  to	  study	  the	  characteristics	  of	  CNPs	  with	  charged	  particle	  radiation,	  in	  
order	  to	  determine	  if	  they	  could	  act	  as	  radiosensitizers	  for	  cancer	  cells	  and/or	  
radioprotectors	  to	  normal,	  non-­‐malignant	  cells.	  The	  ultimate	  objective	  would	  be	  to	  find	  one	  
of	  these	  nanoparticles	  that	  holds	  the	  synergistic	  effect	  of	  enhancing	  the	  rate	  of	  killing	  in	  
tumor	  cells	  while	  simultaneously	  improving	  the	  surviving	  fraction	  of	  normal	  cells.	  One	  
phase	  of	  this	  study	  concentrates	  on	  using	  CNP	  variations	  to	  investigate	  if	  a	  protective	  effect	  
exists	  in	  the	  non-­‐malignant	  184A1	  breast	  cell	  line.	  An	  additional	  phase	  of	  this	  study	  focuses	  
on	  demonstrating	  that	  a	  sensitizing	  effect	  exists	  in	  the	  MCF7	  breast	  tumor	  cell	  line	  
counterpart	  and/or	  the	  22RV1	  prostate	  tumor	  cell	  line	  using	  distinctive	  CNP	  variations.	  	  
Specific	  Aim	  1:	  	  
	   The	  first	  aim	  of	  this	  study	  was	  to	  determine	  if	  a	  specific	  CNP	  treatment	  can	  offer	  
protection	  to	  the	  non-­‐malignant	  184A1	  breast	  epithelial	  cell	  line	  when	  exposed	  to	  proton	  
radiation.	  Non-­‐malignant	  cells	  were	  treated	  with	  different	  types	  of	  varying	  concentrations	  
	   24	  
of	  CNP	  candidates	  24	  hours	  prior	  to	  radiation	  exposure	  to	  determine	  if	  a	  specific	  
nanoparticle	  treatment	  could	  offer	  protective	  characteristics.	  The	  protection	  effect	  was	  
assessed	  using	  MTT	  assay.	   	  
Specific	  Aim	  2:	  	  
	   The	  second	  aim	  of	  this	  study	  was	  to	  verify	  that	  specific	  nanoparticle	  types	  would	  
enhance	  the	  rate	  of	  killing	  in	  tumor	  cells	  when	  exposed	  to	  proton	  radiation.	  Varying	  types	  
and	  concentrations	  of	  CNPs	  were	  administered	  to	  cells	  24	  hours	  prior	  to	  radiation	  
exposure.	  Tumor	  cell	  viability	  was	  assessed	  initially	  with	  an	  MTT	  assay	  and	  measured	  







Chapter	  2:	  Experimental	  Design	  and	  Methods	  
	  
2.1	  Cell	  Culture	  and	  Plating	  
	   Three	  primary	  cell	  lines	  were	  used	  over	  the	  course	  of	  our	  study.	  The	  184A1	  breast	  
epithelial	  cell	  line	  (ATCC®	  CRL-­‐8798™)	  was	  cultured	  using	  Mammal	  Epithelial	  Basal	  
Medium	  (MEBM)	  complete	  media	  (minus	  gentamycin-­‐amphotericin	  B)	  purchased	  from	  
Lonza®	  and	  supplemented	  with	  1	  ng/ml	  cholera	  toxin	  and	  0.005	  mg/ml	  transferrin.	  This	  
non-­‐malignant,	  transformed	  cell	  line	  was	  established	  from	  the	  normal	  mammary	  tissue	  of	  a	  
21-­‐year	  old	  female	  [90].	  The	  22Rv1	  epithelial	  prostate	  carcinoma	  cell	  line	  (ATCC®	  CRL-­‐
2505™)	  was	  cultured	  using	  Roswell	  Park	  Memorial	  Institute	  (RPMI)	  complete	  media	  
purchased	  from	  ATCC®	  and	  supplemented	  with	  a	  final	  concentration	  of	  10%	  Fetal	  Bovine	  
Serum	  (FBS).	  This	  malignant	  cell	  line	  was	  derived	  form	  a	  xenograft	  of	  human	  prostate	  [91].	  
The	  MCF7	  epithelial	  breast	  adenocarcinoma	  cell	  line	  (ATCC®	  HTB-­‐22™)	  was	  cultured	  using	  
Eagle’s	  Minimum	  Essential	  Medium	  (EMEM)	  complete	  media	  purchased	  from	  ATCC®	  and	  
supplemented	  with	  0.01	  mg/ml	  human	  recombinant	  insulin	  and	  a	  final	  concentration	  of	  
10%	  FBS.	  This	  malignant	  cell	  line	  was	  established	  from	  the	  breast	  tissue	  of	  a	  69-­‐year	  old	  
female	  [92].	  
	   Low	  passaged	  cells	  are	  frozen	  and	  stored	  in	  a	  liquid	  nitrogen	  cryogenic	  dewar	  
container	  for	  future	  use.	  To	  thaw	  and	  continue	  a	  passage,	  a	  storage	  vial	  (containing	  roughly	  
105	  cells)	  is	  brought	  to	  room	  temperature	  and	  the	  cells	  are	  diluted	  in	  media.	  The	  
cryoprotective	  agent	  used	  in	  the	  freezing	  process	  is	  removed	  immediately	  by	  centrifuging	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the	  cell	  suspension	  at	  approximately	  125	  x	  g	  for	  10	  min.	  The	  supernatant	  is	  discarded	  and	  
the	  cell	  pellet	  can	  then	  be	  resuspended	  in	  fresh	  growth	  medium.	  Stock	  cultures	  are	  
maintained	  in	  75	  cm2	  (T-­‐75)	  culture	  flasks	  containing	  about	  15	  mL	  of	  media	  and	  incubated	  
at	  37°C	  in	  a	  5%	  CO2	  environment	  until	  they	  reach	  90%	  confluence.	  At	  that	  point,	  the	  cells	  
are	  ready	  to	  use	  for	  the	  first	  step	  of	  the	  experiment.	  
	   On	  the	  day	  for	  the	  initial	  plating	  of	  the	  experiment,	  the	  media	  is	  aspirated	  off	  of	  our	  
nearly	  confluent	  flask	  of	  cells.	  Then	  10	  mL	  of	  Phosphate-­‐Buffered	  Saline	  (PBS)	  is	  added	  to	  
wash	  the	  cells.	  After	  a	  wash,	  the	  cells	  are	  lifted	  via	  trypsinization.	  1	  mL	  of	  0.25%	  
Trypsin/EDTA	  (Ethylenediaminetetraacetic	  acid)	  solution	  (Invitrogen/Life	  
Technologies,Inc.)	  is	  added	  and	  the	  cells	  are	  placed	  into	  the	  incubator.	  This	  helps	  the	  
Trypsin	  work	  to	  detach	  the	  cells	  from	  the	  substrate.	  Observations	  of	  the	  cells	  indicate	  that	  
they	  are	  fully	  trypsinized	  when	  they	  become	  rounded	  and	  detach	  from	  the	  flask	  when	  the	  
flask	  is	  gently	  swirled.	  After	  the	  cells	  have	  lifted,	  9	  mL	  of	  complete	  media	  is	  added	  to	  the	  
flask.	  This	  solution	  is	  mixed	  by	  pipetting	  up	  and	  down	  20	  times	  in	  order	  to	  break	  up	  clumps	  
of	  cells	  and	  create	  a	  single	  cell	  suspension.	  	  
	   From	  the	  suspended	  cells,	  we	  take	  a	  sample	  100	  μL	  aliquot	  in	  order	  to	  perform	  a	  cell	  
count.	  In	  an	  Eppendorf	  tube,	  50	  μL	  of	  the	  sample	  along	  with	  50	  μL	  of	  0.4%	  Trypan	  Blue	  are	  
mixed	  well,	  and	  a	  10	  μL	  aliquot	  of	  that	  is	  loaded	  into	  a	  hemocytometer	  slide.	  The	  loaded	  
slide	  is	  placed	  under	  the	  microscope	  and	  the	  Trypan	  Blue-­‐excluding	  cells	  are	  counted	  in	  
square	  grid	  regions.	  An	  average	  is	  then	  calculated	  using	  the	  cell	  counts	  in	  each	  region.	  
Knowing	  the	  cell	  count	  average	  and	  the	  volume	  of	  one	  of	  the	  grids,	  the	  cell	  concentration	  
can	  be	  determined	  as	  follows:	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avg	  x	  2(Trypan	  Dilution)	  /Volume	  of	  grid(0.1cm	  x	  0.1	  cm	  x	  0.01cm)	  =	  #	  Cells/mL	  
Each	  well	  that	  is	  used	  on	  the	  48-­‐well	  microtiter	  plates	  should	  have	  2x104	  cells.	  Each	  well	  
will	  also	  be	  seeded	  with	  200	  μL	  of	  suspended	  cells.	  This	  results	  in	  a	  concentration	  of	  (2x104	  
cells)/(0.2	  mL)	  =	  1x105	  cells/mL	  and	  a	  dilution	  factor	  equal	  to	  (counted	  #	  
cells/mL)/(1x105	  cells/mL).	  
	   A	  minimum	  volume	  of	  (the	  #	  of	  wells	  that	  are	  receiving	  cells)	  x	  200	  μL	  is	  required,	  
and	  the	  total	  volume	  of	  suspended	  cells	  that	  is	  prepared	  must	  be	  greater	  than	  the	  minimum	  
volume	  required	  to	  allow	  for	  error	  when	  pipetting.	  Therefore	  each	  new	  suspension	  utilizes	  
a	  total	  final	  volume	  that	  is	  greater	  than	  the	  minimum	  required	  volume.	  When	  a	  final	  
amount	  is	  chosen	  the	  volume	  of	  original	  suspended	  cells	  to	  add	  to	  the	  new	  suspension	  can	  
be	  determined,	  
(Total	  Final	  Volume)/(dilution	  factor)	  =	  (volume	  of	  suspended	  cells).	  
Then	  the	  volume	  of	  fresh	  media	  to	  add	  to	  the	  new	  suspension	  is	  what	  remains,	  
(Total	  Final	  Volume)	  –	  (Volume	  of	  suspended	  cells)	  =	  (Volume	  of	  fresh	  media).	  
These	  two	  volumes	  are	  transferred	  to	  a	  test	  tube	  and	  thoroughly	  mixed.	  	  
	   Once	  the	  appropriate	  cell	  dilution	  is	  created,	  the	  plates	  are	  seeded	  for	  the	  
experiment.	  200	  μL	  	  of	  cell	  suspension	  is	  added	  to	  wells	  in	  a	  48-­‐well	  microtiter	  plate.	  The	  
plates	  are	  then	  placed	  in	  the	  incubator	  at	  37°C	  (5%	  CO2)	  for	  24	  hours	  to	  allow	  the	  cells	  to	  
adhere	  to	  the	  bottom	  of	  the	  plate.	  A	  diagram	  of	  the	  plating	  configuration	  is	  shown	  in	  Fig.	  1.	  
The	  reasoning	  for	  this	  configuration	  will	  be	  explained	  later.	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Fig.	  1	  Configuration	  for	  Seeding	  Cells	  in	  a	  48	  Well	  Plate	  
	   	  
	   When	  plating	  is	  completed,	  a	  small	  split	  of	  suspended	  cells	  from	  the	  original	  T-­‐75	  
flask	  is	  added	  to	  a	  new	  T-­‐75	  culture	  flask	  for	  the	  next	  experiment	  run.	  Enough	  fresh	  
complete	  media	  is	  added	  to	  bring	  the	  total	  volume	  up	  to	  approximately	  15	  mL	  and	  the	  flask	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2.2	  Adding	  Nanoparticles	  
	   The	  CNPs	  that	  were	  used	  in	  this	  study	  were	  fabricated	  at	  the	  University	  of	  Central	  
Florida	  (UCF)	  NanoScience	  Technology	  Center	  (NSTC)	  and	  then	  transferred	  to	  ECU.	  	  There	  
are	  several	  different	  methods	  of	  preparation	  that	  are	  used	  in	  order	  to	  achieve	  a	  certain	  
effect	  when	  implemented	  with	  irradiated	  cells	  [18,	  93].	  These	  vacancy-­‐engineered	  CNPs	  of	  
interest	  are	  patented	  and	  therefore	  information	  about	  them	  is	  proprietary	  [94].	  	  
	   One	  method	  of	  their	  preparation	  uses	  a	  microemulsion	  technique	  that	  involves	  
toluene,	  water,	  and	  surfactant	  sodium	  bis(2-­‐ethylhexyl)	  sulfosuccinate	  (AOT)	  [18].	  2.5	  mL	  
of	  0.1	  M	  aqueous	  cerium	  nitrate	  solution	  is	  added	  to	  a	  mixture	  of	  AOT	  that	  is	  dissolved	  in	  
50	  mL	  of	  toluene,	  and	  then	  stirred	  for	  45	  minutes.	  Using	  a	  drop	  method,	  5	  mL	  of	  30%	  
hydrogen	  peroxide	  is	  added	  and	  the	  subsequent	  reaction	  continues	  for	  one	  hour.	  Then	  the	  
mixture	  is	  left	  to	  separate	  into	  layers,	  with	  the	  upper	  layer	  consisting	  of	  toluene	  and	  non-­‐
clustered	  ceria	  nanoparticles	  and	  the	  bottom	  layer	  containing	  the	  aqueous	  phase.	  30%	  
ammonia	  is	  added	  in	  order	  to	  precipitate	  the	  CNPs,	  and	  then	  they	  are	  washed	  with	  acetone	  
and	  water	  to	  completely	  remove	  the	  surfactant.	  Then	  the	  CNPs	  are	  suspended	  at	  a	  5mM	  
concentration	  in	  deionized	  water.	  
	   Another	  method	  uses	  simple	  wet	  chemical	  procedures	  and	  yields	  CNPs	  with	  a	  
higher	  surface	  Ce3+	  concentration.	  In	  this	  preparation,	  cerium	  nitrate	  hexahydrate	  is	  first	  
dissolved	  in	  deionized	  water.	  To	  remove	  undissolved	  impurities,	  the	  solution	  is	  then	  
filtered	  using	  a	  20	  nm	  filter.	  The	  cerium	  solution	  is	  oxidized	  using	  hydrogen	  peroxide	  and	  
then	  stirred	  overnight.	  Afterwards,	  the	  CNPs	  are	  dialyzed	  against	  deionized	  water	  to	  
remove	  excess	  oxidizers	  and	  nitrate	  ions	  from	  the	  solution.	  A	  similar	  type	  preparation	  is	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used	  to	  produce	  CNPs	  with	  a	  higher	  surface	  Ce4+	  concentration,	  with	  the	  only	  change	  in	  
methodology	  being	  ammonium	  hydroxide	  is	  used	  instead	  of	  hydrogen	  peroxide	  [65,	  72].	  
	   To	  properly	  characterize	  the	  CNPs,	  x-­‐ray	  photoelectron	  spectroscopy	  (XPS)	  and	  
high-­‐resolution	  transmission	  electron	  microscopy	  (HRTEM)	  were	  used.	  These	  CNPs	  have	  
been	  characterized	  as	  ultrafine,	  being	  uniformly	  distributed,	  and	  having	  nanocrystallinity	  
[17,	  95].	  The	  physiochemical	  properties	  of	  these	  CNPs	  reveal	  that	  they	  are	  spherical	  in	  
shape,	  having	  a	  crystalline	  fluorite	  structure	  with	  diameters	  ranging	  from	  5-­‐18	  nm	  and	  
they	  have	  hydrodynamic	  sizes	  of	  10-­‐350	  nm	  in	  ddH!O	  (double-­‐distilled	  water)	  depending	  
on	  their	  morphology	  [84,	  93].	  Oxygen	  vacancies	  that	  are	  created	  by	  surface	  chemical	  
reactions	  allow	  Ce3+	  to	  be	  present	  in	  the	  CNP	  crystal	  lattice	  [96].	  An	  XPS	  spectrum	  of	  the	  
synthesized	  CNPs	  shows	  distinctive	  peaks	  that	  demonstrate	  the	  presence	  of	  the	  mixed	  
valence	  (Ce3+	  and	  Ce4+)	  state	  [17].	  
	   After	  the	  plated	  cells	  have	  incubated	  overnight,	  the	  nanoparticles	  are	  added	  to	  each	  
well	  at	  appropriate	  concentrations.	  The	  stock	  CNPs	  are	  sonicated	  prior	  to	  use	  with	  a	  Sonic	  
Dismembrator	  (Fisher	  Scientific™	  Model	  50)	  for	  2-­‐3	  minutes	  at	  25%	  power.	  Concentrations	  
ranging	  from	  10	  nanoMolar(nM)	  to	  10	  microMolar(μM)	  are	  required	  for	  each	  well	  
receiving	  the	  nanoparticle	  treatment.	  The	  initial	  5	  miliMolar(mM)	  concentration	  of	  
suspended	  nanoparticles	  requires	  that	  serial	  dilutions	  be	  performed	  for	  each	  nanoparticle	  
type	  used.	  	  
	   The	  serial	  dilution	  process	  begins	  by	  labeling	  five	  tubes	  with	  the	  nanoparticle	  type	  
followed	  by	  A,	  B,	  C,	  D,	  or	  E.	  Then	  0.9	  mL	  of	  media	  is	  added	  to	  each	  of	  the	  five	  tubes.	  0.1	  mL	  
of	  the	  5	  mM	  suspended	  nanoparticles	  is	  added	  to	  tube	  A	  and	  mixed	  thoroughly.	  Then	  0.1	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mL	  of	  the	  diluted	  suspended	  nanoparticles	  from	  tube	  A	  is	  added	  to	  tube	  B.	  After	  mixing	  
well,	  0.1	  mL	  of	  the	  diluted	  suspended	  nanoparticles	  from	  tube	  B	  is	  added	  to	  tube	  C.	  Once	  
this	  is	  fully	  mixed,	  the	  suspension	  in	  tube	  C	  is	  now	  at	  a	  5	  μM	  concentration.	  This	  procedure	  
continues	  for	  tube	  D	  and	  E.	  Once	  this	  is	  fully	  mixed,	  the	  suspension	  in	  tube	  E	  is	  now	  at	  a	  50	  
nM	  concentration.	  Then	  50	  μL	  of	  the	  diluted	  suspended	  nanoparticles	  from	  each	  tube	  is	  
added	  to	  each	  appropriate	  well	  of	  the	  48-­‐well	  microtiter	  plate.	  A	  diagram	  of	  the	  serial	  
dilution	  process	  is	  shown	  in	  Fig.	  2.	  
	  
Fig.	  2	  Serial	  Dilution	  Process	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   Each	  well	  had	  200	  μL	  of	  media	  before	  the	  addition	  of	  nanoparticles	  from	  plating	  day.	  
The	  addition	  of	  the	  50	  μL	  of	  diluted	  suspended	  nanoparticles	  results	  in	  a	  final	  volume	  of	  
250	  μL	  and	  a	  nanoparticle	  dilution	  ratio	  of	  1:5	  from	  any	  of	  the	  prepared	  tubes	  previously	  
described.	  For	  example,	  the	  5	  μM	  concentration	  from	  tube	  C	  becomes	  a	  1	  μM	  final	  
concentration	  once	  added	  to	  the	  appropriate	  well.	  In	  order	  to	  ensure	  equal	  volumes	  in	  all	  
appropriate	  well	  plates,	  50	  μL	  of	  complete	  media	  is	  added	  to	  the	  wells	  that	  did	  not	  receive	  
nanoparticles.	  The	  plates	  are	  then	  returned	  to	  the	  incubator	  at	  37°C	  (5%	  CO2),	  and	  the	  cells	  
are	  allowed	  to	  absorb	  the	  nanoparticle	  treatment	  for	  24	  hours.	  
2.3	  Proton	  Irradiation	  
	   The	  Accelerator	  Laboratory	  at	  East	  Carolina	  University	  houses	  a	  2	  MV	  tandem	  
Pelletron	  accelerator	  that	  is	  capable	  of	  producing	  ion	  beams	  with	  diverse	  energies	  and	  
charge	  states	  for	  the	  purpose	  of	  studying	  atomic	  collisions	  [97].	  For	  this	  study,	  the	  
accelerator	  is	  operated	  to	  create	  a	  proton	  beam	  that	  traverses	  through	  vacuum,	  using	  
steering	  and	  focusing	  instruments,	  to	  an	  exit	  point	  where	  the	  biological	  samples	  are	  
exposed.	  The	  schematic	  of	  the	  accelerator	  system	  is	  shown	  below	  in	  Fig.	  3.	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   This	  process	  of	  creating	  and	  harnessing	  the	  ion	  beam	  starts	  with	  the	  cesium-­‐sputter	  
ion	  source	  (Ionex	  Corporation	  model	  860A).	  This	  source	  is	  capable	  of	  producing	  various	  
atomic	  and	  molecular	  ions	  as	  well	  as	  negative	  ion	  beams	  in	  the	  microampere	  range	  [98,	  
99].	  This	  particular	  ion	  sputter	  source	  and	  the	  list	  of	  potential	  ions	  available	  to	  be	  produced	  
with	  their	  relative	  abundances	  have	  been	  well	  documented	  [100].	  First,	  a	  cesium	  oven	  
reservoir	  is	  heated	  in	  order	  for	  cesium	  vapors	  to	  migrate	  into	  the	  ion	  source	  chamber	  that	  
contains	  a	  copper	  cathode	  and	  heated	  ionizer.	  Cesium	  vapors	  come	  in	  contact	  with	  the	  
heated	  ionizer	  coil	  becoming	  positively	  ionized	  Cs+.	  The	  cathode	  is	  held	  at	  a	  negative	  
potential	  and	  therefore	  attracts	  the	  Cs+	  ions.	  These	  Cs+	  ions,	  due	  to	  their	  momentum,	  will	  
sputter	  off	  atoms	  when	  they	  slam	  into	  the	  cathode	  material.	  When	  these	  atoms	  penetrate	  
through	  the	  condensed	  cesium,	  an	  electron	  is	  captured	  in	  the	  process	  and	  produces	  
negative	  ions,	  which	  form	  the	  initial	  beam.	  In	  this	  particular	  study,	  protons	  are	  appropriate	  
for	  investigation.	  Therefore,	  H-­‐	  ions	  are	  produced	  using	  a	  cathode	  material	  comprised	  of	  
Titanium	  Hydride	  (TiH).	  The	  cathode	  itself	  is	  10	  mm	  wide	  and	  12.5	  mm	  long	  with	  a	  cone	  
shaped	  front	  that	  has	  a	  1.6	  mm	  well	  drilled	  5mm	  into	  its	  center.	  This	  well	  is	  tightly	  packed	  
with	  TiH	  powder.	  These	  ions	  are	  focused	  into	  a	  beam	  dictated	  by	  the	  defined	  potential	  
surfaces	  of	  the	  cathode	  and	  ionizer	  potentials,	  while	  other	  ions	  (including	  Cs+	  ions)	  are	  
scattered.	  
	   A	  30	  kV	  potential	  initially	  extracts	  the	  negative	  ion	  beam	  along	  a	  1	  m	  region	  and	  the	  
beam	  is	  focused	  with	  an	  electrostatic	  Einzel	  lens.	  The	  Einzel	  lens	  can	  vary	  the	  surrounding	  
electric	  field	  to	  focus	  the	  beam	  using	  ion	  optics	  [101].	  The	  H-­‐	  ions	  are	  then	  selected	  based	  
on	  their	  momentum	  with	  an	  inflection	  bipolar	  magnet	  and	  then	  focused	  again	  using	  
another	  Einzel	  lens	  followed	  by	  a	  pair	  of	  electrostatic	  steerers.	  Then	  the	  H-­‐	  beam	  is	  injected	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into	  the	  2	  MV	  tandem	  Pelletron	  accelerator	  (National	  Electrostatic	  Corporation	  model	  
6SDH-­‐2).	  
	   Electric	  charge	  accumulates	  in	  the	  accelerator	  vessel	  by	  means	  of	  two	  Pelletron	  
chains	  in	  a	  closed	  pulley	  system.	  The	  chains	  are	  metal	  pellets	  connected	  by	  nylon	  links.	  In	  
this	  system,	  a	  negatively	  charged	  inductor	  pushes	  electrons	  off	  the	  pellets	  while	  they	  are	  in	  
contact	  with	  the	  grounded	  drive	  pulley.	  They	  retain	  their	  charge	  as	  they	  exit	  the	  inductor	  
and	  continue	  on	  to	  the	  high	  voltage	  terminal	  where	  the	  reverse	  process	  takes	  place.	  The	  
chain	  passes	  through	  a	  suppressor	  to	  prevent	  arcing	  as	  the	  pellets	  deposit	  positive	  charge	  
onto	  the	  terminal	  pulley	  [102].	  This	  is	  an	  enclosed	  system	  operating	  inside	  a	  pressurized	  
tank	  that	  contains	  up	  to	  550	  kPa	  of	  SF6	  insulating	  gas	  to	  prevent	  discharge.	  	  
	   As	  the	  ion	  beam	  enters	  the	  accelerator,	  the	  H-­‐	  ions	  are	  attracted	  to	  the	  positive	  high	  
voltage	  terminal.	  In	  the	  center	  of	  the	  vessel,	  nitrogen	  gas	  (N2)	  is	  present	  that	  strips	  off	  
electrons	  from	  the	  H-­‐	  ions	  making	  them	  positively	  charged	  H+	  ions	  (protons).	  Then	  the	  
positive	  ions	  are	  accelerated	  again	  as	  they	  are	  repelled	  towards	  the	  ground	  potential,	  
completing	  the	  tandem	  process	  of	  acceleration.	  Using	  this	  technique,	  the	  accelerator	  at	  ECU	  
can	  generate	  singly	  charged	  ions	  up	  to	  4	  MeV.	  	  The	  National	  Electrostatic	  Corporation	  
(NEC)	  details	  the	  design	  and	  operation	  of	  these	  type	  accelerators	  [103].	  
	   As	  H+	  ions	  exit	  the	  accelerator,	  the	  beam	  is	  focused	  with	  a	  pair	  of	  quadrupole	  
magnets.	  An	  analyzing	  magnet	  selects	  the	  beam	  of	  the	  appropriate	  mass	  to	  charge	  ratio	  and	  
steers	  it	  down	  the	  left	  15°	  beamline	  to	  the	  biological	  samples.	  A	  diagram	  of	  the	  15°	  
beamline	  is	  shown	  in	  Fig.	  4.	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   The	  pressure	  in	  the	  experimental	  beamline	  is	  maintained	  around	  the	  10-­‐7	  torr	  range	  
with	  a	  turbomolecular	  pump	  and	  an	  ionization	  pressure	  gauge	  is	  used	  to	  measure	  and	  
monitor	  the	  vacuum	  pressure.	  Inside	  the	  ion	  gauge,	  a	  heated	  filament	  releases	  electrons	  
that	  are	  attracted	  to	  a	  positively	  charge	  grid.	  The	  electrons	  can	  collide	  with	  gas	  molecules	  
on	  their	  way	  to	  the	  grid	  creating	  gas	  ions.	  These	  gas	  ions	  are	  collected	  with	  a	  negatively	  
charged	  wire	  and	  the	  resulting	  current	  can	  be	  measured	  to	  determine	  the	  vacuum	  
pressure.	  A	  fast-­‐shut	  valve	  is	  mounted	  upstream	  in	  the	  beamline	  so	  that	  if	  there	  were	  a	  
sudden	  loss	  of	  pressure	  it	  would	  trigger	  to	  preserve	  the	  vacuum	  further	  up	  the	  line.	  Down	  
the	  beamline,	  a	  feedthrough	  block	  is	  positioned	  with	  a	  quartz	  crystal	  attached	  that	  will	  
fluoresce	  when	  exposed	  to	  the	  beam.	  The	  beam	  spot	  can	  be	  seen	  through	  the	  viewing	  
window	  on	  the	  side	  of	  the	  beamline.	  The	  beam	  current	  can	  then	  be	  measured	  with	  a	  
Faraday	  cup	  that	  is	  mounted	  on	  the	  beamline	  right	  before	  the	  beam	  exits	  through	  a	  12.5	  
μm	  titanium	  foil	  vacuum	  window	  into	  open	  air.	  The	  titanium	  foil	  is	  epoxied	  to	  a	  brass	  
beamline	  blank	  with	  a	  1.4	  cm	  aperture	  drilled	  in	  the	  center.	  This	  window	  is	  appropriately	  
small	  as	  to	  limit	  the	  amount	  of	  energy	  loss	  of	  the	  ion	  beam	  due	  to	  nuclei	  interactions	  in	  the	  
foil.	  As	  the	  beam	  exists	  the	  foil,	  it	  propagates	  through	  open	  air	  before	  reaching	  a	  monolayer	  
of	  cells	  in	  the	  center	  of	  a	  well	  on	  a	  48	  well	  microtiter	  plate.	  A	  picture	  of	  the	  end	  of	  the	  L15	  
beamline	  is	  shown	  in	  Fig.	  5.	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Fig.	  5	  A	  picture	  of	  the	  target	  that	  is	  held	  at	  the	  end	  of	  the	  L15	  beamline.	  A	  vacuum	  window	  
is	  attached	  to	  the	  end	  of	  the	  four-­‐way	  cross.	  The	  beam	  exits	  the	  window	  and	  strikes	  the	  
biological	  sample	  in	  the	  48-­‐well	  plate.	  
	   	  
	   To	  ensure	  the	  uniformity	  of	  the	  beam,	  the	  beam	  intensity	  profile	  is	  imaged	  using	  a	  
cerium-­‐doped	  yttrium	  aluminum	  garnet	  (YAG)	  crystal.	  This	  crystal	  scintillates	  when	  
exposed	  to	  charged	  particles.	  It	  is	  specifically	  placed	  at	  the	  location	  where	  the	  cells	  are	  
irradiated	  and	  is	  fixed	  in	  a	  48-­‐well	  microtiter	  plate	  sample	  to	  simulate	  a	  monolayer	  of	  cells	  
at	  the	  bottom	  of	  one	  of	  the	  wells.	  A	  diagram	  is	  shown	  in	  Fig.	  6	  of	  the	  exact	  location	  of	  the	  
YAG	  crystal	  in	  the	  E5	  well	  of	  the	  sample	  plate.	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Fig.	  6	  A	  depiction	  of	  the	  positioning	  of	  the	  YAG	  scintillation	  crystal	  in	  the	  E5	  well	  of	  a	  
sample	  plate.	  
	   	  
	   In	  this	  arrangement,	  a	  180	  degree	  rotation	  of	  the	  plate	  allows	  the	  B4	  well	  to	  be	  in	  
line	  with	  the	  beam.	  This	  current	  setup	  allows	  for	  two	  irradiated	  wells	  per	  plate.	  A	  camera	  
was	  mounted	  directly	  behind	  the	  plate	  holder	  and	  focused	  on	  the	  well	  containing	  the	  YAG	  
crystal.	  This	  camera	  allows	  an	  image	  to	  be	  captured	  using	  XCAP®	  for	  Windows.	  The	  image	  
can	  then	  characterized	  using	  ImageJ,	  a	  public	  domain	  Java	  based	  script	  program	  developed	  
at	  the	  National	  Institute	  of	  Health	  [104].	  ImageJ	  is	  used	  to	  process	  and	  display	  the	  image	  as	  
a	  3D	  representation	  that	  shows	  deviances	  in	  the	  scintillation	  of	  the	  crystal,	  which	  indicates	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quadrupole	  magnets	  and	  electrostatic	  steerers	  to	  obtain	  the	  desired	  uniformity.	  A	  visual	  of	  
the	  scintillation	  and	  capturing	  process	  is	  shown	  in	  Fig.	  7.	  A	  sample	  representation	  of	  the	  
beam	  intensity	  profile	  adjusted	  for	  uniformity	  is	  shown	  in	  Fig.	  8.	  
	  
Fig.	  7	  A	  visual	  of	  the	  scintillation	  and	  image	  capturing	  process	  that	  occurs	  in	  order	  to	  
characterize	  the	  beam	  intensity	  profile.	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Fig.	  8	  An	  example	  of	  the	  intensity	  profile	  from	  the	  cerium-­‐doped	  YAG	  scintillation	  crystal	  
bombarded	  with	  protons	  adjusted	  for	  uniformity.	  This	  image	  was	  taken	  with	  a	  camera	  at	  
the	  end	  of	  the	  beamline	  and	  then	  processed	  using	  ImageJ	  software.	  
	  
	   While	  adjusting	  the	  beam	  uniformity,	  it	  is	  also	  necessary	  to	  verify	  a	  steady	  beam	  
current	  in	  time	  in	  order	  to	  avoid	  a	  surge	  that	  would	  cause	  a	  spike	  in	  the	  dose	  received	  by	  
our	  samples.	  This	  usually	  requires	  waiting	  long	  periods	  of	  time	  in	  between	  each	  tuning	  of	  a	  
parameter	  for	  the	  beam	  to	  stabilize.	  	  
	   With	  the	  beam	  uniformity	  in	  place,	  the	  dose	  can	  be	  calculated	  using	  equation	  1.3.	  
The	  dosimetry	  is	  determined	  using	  the	  measured	  beam	  current	  of	  the	  faraday	  cup,	  the	  
beam	  profile,	  and	  the	  calculated	  energy	  deposition	  using	  the	  stopping	  powers	  predicted	  by	  
Stopping	  and	  Range	  of	  Ions	  in	  Matter	  (SRIM)	  code	  [19].	  The	  SRIM	  code	  gives	  the	  stopping	  
power	  and	  range	  of	  ion	  into	  matter	  at	  energies	  up	  to	  2	  GeV/amu	  through	  means	  of	  a	  
quantum	  mechanical	  treatment	  of	  ion-­‐atom	  collisions	  and	  uses	  statistical	  algorithms	  that	  
average	  the	  results	  from	  calculated	  ion	  collisions	  to	  use	  throughout	  the	  intervening	  gaps	  
	   42	  
[19].	  The	  SRIM	  program	  uses	  this	  treatment	  for	  various	  types	  of	  material.	  
	   To	  define	  the	  dose	  received	  by	  the	  cells,	  the	  LET	  of	  the	  beam	  must	  first	  be	  calculated	  
to	  determine	  the	  energy	  lost	  to	  each	  material	  traversed	  by	  the	  beam.	  	  The	  stopping	  power	  
and	  density	  are	  used	  to	  establish	  the	  LET	  of	  the	  first	  material	  as	  follows.	  
	   𝐿𝐸𝑇 = −
𝑑𝐸
𝜌𝑑𝑥 ∗ 𝜌	   (2.1)	  
Then	  the	  material’s	  thickness	  is	  used	  to	  determine	  the	  energy	  loss	  of	  the	  beam	  as	  it	  exits	  
the	  medium.	  	  
	   𝐸!"## = 𝐿𝐸𝑇 ∗ ∆𝑥	   (2.2)	  
Now	  the	  remaining	  energy	  of	  the	  beam	  can	  be	  calculated	  and	  used	  as	  the	  starting	  value	  for	  
the	  next	  LET	  calculation.	  
	   𝐸!"#$%&%&' = 𝐸! − 𝐸!"##	   (2.3)	  
	   This	  process	  continues	  for	  each	  subsequent	  material	  that	  the	  beam	  encounters	  
along	  its	  path.	  The	  beam	  initially	  crosses	  the	  12.5	  μm	  titanium	  foil	  window	  before	  traveling	  
3.1	  cm	  of	  air	  into	  a	  single	  layer	  of	  identical	  epithelial	  cells	  with	  a	  presumed	  thickness	  of	  5	  
μm	  that	  is	  consistent	  with	  comparable	  studies	  [105,	  106].	  This	  generalization	  is	  necessary	  
in	  determining	  a	  relative	  dose	  to	  the	  cells,	  however	  in	  reality	  the	  cells	  vary	  in	  shape	  and	  
size	  but	  this	  variance	  is	  not	  critical	  and	  the	  estimation	  is	  sufficient	  for	  dose	  calculations.	  A	  
schematic	  of	  the	  spacing	  at	  the	  end	  of	  the	  beamline	  is	  shown	  in	  Fig.	  9.	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   For	  the	  3	  MeV	  protons	  that	  were	  used	  in	  this	  study,	  the	  energy	  loss	  in	  the	  foil	  was	  
determined	  to	  be	  13%.	  The	  energy	  loss	  of	  the	  beam	  to	  the	  air	  was	  determined	  to	  be	  19%.	  
This	  resulted	  in	  an	  incident	  energy	  on	  the	  cells	  that	  was	  approximately	  1	  MeV	  less	  than	  the	  
initial	  beam	  energy	  in	  the	  beamline	  prior	  to	  exiting	  vacuum.	  	  
	   The	  dose	  rate	  was	  determined	  at	  the	  midpoint	  of	  the	  cell	  using	  the	  mass	  stopping	  
power	  (dE/ρdx)	  and	  the	  fluence	  rate	  (𝜑)	  from	  the	  measured	  current	  in	  the	  faraday	  cup.	  
	   𝐷 = 𝜑
𝑑𝐸
𝜌𝑑𝑥 ∗ 1.6×10
!!	   (2.4)	  
Since	  the	  mass	  stopping	  power	  is	  measured	  in	  MeV	  cm2/mg	  and	  the	  fluence	  rate	  has	  units	  
of	  cm-­‐2	  sec-­‐1,	  a	  conversion	  factor	  of	  1.6×10!!	  is	  needed	  to	  convert	  MeV/mg	  to	  the	  standard	  
unit	  of	  dose	  Gy	  (J/kg)	  and	  produce	  a	  dose	  rate	  that	  is	  measured	  in	  Gy/sec.	  Analyzing	  the	  
dose	  rate	  at	  the	  midpoint	  of	  the	  cell	  is	  consistent	  with	  previous	  studies	  [106-­‐108].	  
	   This	  dose	  rate	  is	  used	  to	  calculate	  the	  correct	  beam	  exposure	  time	  needed	  for	  the	  
cells	  to	  receive	  a	  prescribed	  dose	  of	  radiation.	  The	  samples	  can	  then	  be	  exposed	  using	  the	  
Farady	  cup	  as	  an	  open/close	  shutter	  valve,	  controlling	  the	  amount	  of	  time	  it	  stays	  open	  
with	  a	  computer-­‐operated	  precision	  timer.	  
	   Once	  the	  proton	  beam	  has	  been	  stabilized	  on	  target,	  every	  setting	  has	  been	  
optimized	  to	  create	  uniformity,	  and	  the	  dose	  is	  calculated,	  then	  the	  cells	  are	  ready	  to	  be	  
irradiated.	  First	  the	  cells	  are	  washed	  with	  media,	  being	  certain	  not	  to	  cross	  contaminate	  
between	  the	  wells.	  Then	  the	  cells	  in	  their	  well	  plates	  are	  transported	  to	  the	  accelerator	  lab.	  
Even	  the	  non-­‐irradiated	  plates	  are	  transported	  along	  with	  the	  rest	  of	  the	  other	  plates	  to	  the	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accelerator	  lab	  to	  ensure	  that	  all	  groups	  are	  treated	  equally.	  	  
	   The	  appropriate	  plates	  are	  irradiated	  with	  an	  external	  proton	  beam	  that	  is	  extracted	  
at	  the	  exit	  point	  through	  the	  titanium	  foil	  window.	  The	  plates	  are	  randomized	  and	  exposed	  
as	  quickly	  as	  possible	  to	  minimize	  the	  time	  that	  the	  cells	  sit	  without	  media.	  During	  this	  
process,	  the	  beam	  current	  is	  monitored	  for	  stability.	  If	  there	  is	  even	  a	  slight	  fluctuation,	  the	  
dose	  time	  is	  recalculated	  to	  guarantee	  that	  all	  of	  our	  samples	  receive	  the	  same	  relative	  
dose.	  Once	  the	  irradiation	  is	  completed,	  the	  cells	  are	  immediately	  transported	  back	  to	  the	  
cell	  culture	  lab.	  Each	  well	  is	  brought	  back	  up	  to	  a	  volume	  of	  200	  μL	  with	  fresh	  complete	  
media.	  The	  plates	  are	  then	  returned	  to	  the	  incubator	  and	  cells	  are	  allowed	  to	  incubate	  at	  
37°C	  (5%	  CO2)	  and	  recover	  for	  24	  hours.	  It	  is	  at	  this	  point	  in	  the	  experiment	  that	  samples	  
are	  handled	  according	  to	  which	  assay	  is	  to	  be	  performed.	  
2.4	  MTT	  Assay	  
	   The	  Microculture	  Tetrazolium	  Technique(MTT)	  assay	  was	  used	  to	  assess	  cell	  
viability	  after	  exposure	  to	  radiation.	  For	  184A1	  cells,	  the	  MTT	  assay	  was	  performed	  24	  
hours	  after	  irradiation.	  For	  the	  22Rv1	  and	  MCF7	  cells,	  the	  MTT	  assay	  was	  performed	  72	  
hours	  after	  irradiation.	  	  It	  is	  a	  colorimetric	  assay	  that	  measures	  cell	  viability	  by	  the	  
reduction	  of	  tetrazolium	  salts.	  For	  this	  study	  we	  used	  Thiazolyl	  Blue	  Tetrazolium	  Bromide	  
MTT	  (3-­‐(4,5-­‐Dimethyl-­‐2-­‐thiazolyl)-­‐2,5-­‐diphenyl-­‐2H-­‐tetrazolium	  bromide)	  purchased	  from	  
Sigma-­‐Aldrich®.	  The	  cells	  that	  are	  metabolically	  active	  will	  reduce	  the	  MTT	  using	  
dehydrogenase	  enzymes	  yielding	  intracellular	  purple	  formazan.	  The	  amount	  of	  purple	  
formazan	  produced	  can	  be	  quantified	  using	  spectrophotometry.	  The	  ending	  result	  from	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this	  assay	  describes	  metabolic	  activity	  and	  also	  lack	  of	  activity	  due	  to	  events	  such	  as	  
apoptosis,	  necrosis,	  cell	  arrestment,	  etc.	  
	   The	  assay	  is	  performed	  as	  follows.	  44.5	  μL	  of	  5	  mg/ml	  MTT	  reagent	  (dissolved	  in	  
PBS)	  is	  added	  to	  every	  well	  in	  the	  experiment	  (including	  two	  background	  control	  wells	  on	  
each	  plate).	  Then	  the	  cells	  are	  allowed	  to	  incubate	  at	  37°C	  (5%	  CO2)	  for	  about	  3	  hours.	  
After	  this	  incubation	  time,	  the	  media	  is	  removed	  carefully	  from	  each	  well	  as	  to	  not	  disturb	  
the	  purple	  crystal	  precipitate	  at	  the	  bottom.	  Then	  400	  μL	  of	  100%	  2-­‐propanol	  is	  added	  to	  
every	  well	  to	  resuspend	  the	  purple	  crystals.	  The	  contents	  of	  each	  well	  are	  mixed	  until	  the	  
crystals	  are	  completely	  dissolved.	  Once	  these	  suspensions	  are	  complete,	  they	  are	  measured	  
for	  their	  absorbance	  in	  a	  Tecan	  plate	  reader	  (Infinite	  200PRO).	  The	  absorbance	  is	  
measured	  at	  a	  wavelength	  of	  570	  nm	  using	  the	  Magellan™	  software	  program	  and	  the	  values	  
are	  exported	  to	  an	  Excel	  spreadsheet.	  
	   The	  percent	  of	  the	  primary	  control	  was	  calculated	  for	  each	  experimental	  group.	  
First	  the	  average	  absorbance	  values	  for	  the	  background	  wells	  were	  subtracted	  from	  the	  all	  
other	  values.	  Then	  the	  average	  values	  for	  each	  experimental	  group	  were	  calculated	  and	  
divided	  by	  the	  primary	  control	  group	  average.	  This	  normalizes	  the	  primary	  control	  group	  
to	  100%	  and	  represents	  the	  other	  experimental	  groups	  as	  a	  percent	  of	  that	  primary	  
control.	  The	  standard	  error	  that	  was	  calculated	  for	  each	  group	  is	  represented	  as	  the	  
standard	  deviation	  divided	  by	  the	  square	  root	  of	  the	  sample	  size.	  For	  the	  normalization,	  
these	  errors	  were	  added	  in	  quadrature.	  A	  typical	  layout	  for	  this	  type	  assay	  included	  6-­‐8	  
samples	  per	  experimental	  treatment.	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2.5	  Clonogenic	  Assay	  
	   The	  clonogenic	  (or	  colony)	  assay	  was	  used	  to	  assess	  cell	  proliferation	  in	  tumorous	  
populations	  after	  radiation	  exposure.	  To	  perform	  the	  colony	  assay,	  a	  small	  amount	  of	  a	  
sample	  population	  in	  the	  well	  of	  a	  48-­‐well	  plate	  is	  seeded	  into	  the	  well	  of	  a	  6-­‐well	  plate.	  In	  
order	  to	  do	  this	  properly,	  a	  serial	  dilution	  must	  be	  performed.	  Since	  the	  cells	  at	  the	  
beginning	  of	  the	  experiment	  were	  initially	  plated	  with	  an	  approximate	  density	  of	  2x104	  
cells/well,	  and	  since	  Rv1	  cells	  (for	  example)	  have	  a	  theoretical	  doubling	  time	  of	  around	  40	  
hours	  [109],	  then	  after	  accounting	  for	  the	  initial	  lag	  phase	  of	  plating,	  at	  least	  one	  population	  
doubling	  has	  completed	  since	  the	  initial	  plating.	  This	  results	  in	  an	  estimated	  4x104	  cells	  
being	  present	  in	  the	  wells	  of	  the	  control	  plates.	  Using	  this	  estimated	  density,	  a	  serial	  
dilution	  is	  performed	  to	  reduce	  the	  number	  of	  cells	  per	  well	  to	  an	  order	  of	  magnitude	  
closer	  to	  the	  targeted	  final	  seeding	  density	  of	  200	  cells	  per	  well.	  To	  avoid	  confusion,	  the	  
wells	  that	  were	  originally	  plated	  with	  cells	  and	  media	  are	  referred	  to	  as	  the	  “sample	  wells”	  
and	  the	  wells	  in	  the	  serial	  dilution	  are	  referred	  to	  as	  wells	  A	  and	  B,	  respectively.	  The	  final	  
seeding	  is	  prepared	  in	  6-­‐well	  plates.	  	  
	   For	  each	  well	  on	  every	  plate	  that	  has	  cells	  and	  media,	  two	  other	  empty	  wells	  are	  
chosen	  on	  the	  same	  plate	  to	  use	  for	  a	  serial	  dilution	  (referenced	  hereafter	  as	  wells	  A	  and	  B,	  
respectively).	  The	  media	  from	  the	  sample	  well	  is	  transferred	  to	  well	  A	  in	  the	  series.	  Then	  
100	  μL	  of	  0.25%	  Trypsin	  (w/	  EDTA)	  is	  added	  to	  each	  sample	  well.	  The	  plates	  are	  allowed	  to	  
incubate	  for	  about	  five	  minutes	  or	  until	  cells	  in	  each	  sample	  well	  become	  rounded	  and	  
detach	  when	  the	  plate	  is	  lightly	  shaken.	  Then	  700	  μL	  of	  fresh	  complete	  media	  is	  added	  to	  
each	  sample	  well	  and	  the	  contents	  of	  each	  well	  are	  mixed	  up	  and	  down	  20	  times	  with	  the	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pipette	  to	  break	  up	  cell	  clusters.	  The	  cells	  are	  then	  suspended	  in	  the	  media.	  The	  contents	  of	  
each	  sample	  well	  are	  then	  transferred	  to	  its	  associated	  well	  A.	  This	  results	  in	  well	  A	  having	  
a	  total	  volume	  of	  1	  mL	  (200	  μL	  of	  original	  media,	  100	  μL	  of	  Trypsin,	  and	  700	  μL	  of	  fresh	  
media).	  The	  contents	  of	  well	  A	  are	  mixed	  up	  and	  down	  20	  times	  with	  the	  pipette.	  
	   After	  the	  contents	  are	  mixed,	  100	  μL	  of	  suspended	  cells	  is	  taken	  from	  well	  A	  and	  
deposited	  to	  each	  corresponding	  well	  B	  in	  triplicate.	  Also	  900	  μL	  of	  fresh	  complete	  media	  is	  
added	  to	  well	  B	  and	  mixed	  up	  and	  down	  20	  times	  with	  the	  pipette,	  bringing	  the	  total	  
volume	  up	  to	  1	  mL.	  At	  this	  point,	  in	  each	  well	  B,	  the	  number	  of	  cells	  has	  been	  reduced	  to	  
approximately	  4000	  cells.	  Then	  we	  take	  50	  μL	  of	  suspended	  cells	  from	  each	  well	  B	  to	  
separate	  wells	  on	  6-­‐well	  plates	  and	  label	  the	  new	  plates	  accordingly.	  This	  process	  results	  in	  
a	  targeted	  final	  seeding	  density	  of	  200	  cells	  per	  well.	  Roughly	  2	  mL	  of	  fresh	  complete	  media	  
is	  then	  added	  to	  each	  well	  on	  the	  new	  6-­‐well	  plates	  for	  the	  colonies	  to	  grow.	  All	  of	  the	  6-­‐
well	  plates	  are	  then	  placed	  in	  the	  incubator	  and	  the	  cells	  are	  allowed	  to	  incubate	  at	  37°C	  
(5%	  CO2)	  for	  at	  least	  10	  days,	  or	  until	  the	  wells	  develop	  scorable	  colonies.	  A	  diagram	  of	  the	  
serial	  dilution	  process	  within	  the	  48	  well	  plates	  is	  shown	  in	  Fig.	  10.	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Fig.	  10	  The	  explicit	  configuration	  selected	  for	  lifting	  and	  diluting	  the	  irradiated	  cell	  
population	  within	  a	  48-­‐well	  plate.	  The	  serial	  dilution	  process	  is	  performed	  in	  triplicate	  for	  
each	  sample	  well.	  
	  
	   Colonies	  are	  considered	  scorable	  when	  they	  are	  comprised	  of	  at	  least	  50	  cells,	  which	  
indicates	  that	  the	  originally	  plated	  cell	  has	  undergone	  at	  least	  six	  cycles	  of	  division.	  22RV1	  
cells,	  for	  example,	  have	  a	  theoretical	  doubling	  time	  of	  around	  40	  hours	  [109],	  thus	  
requiring	  approximately	  ten	  days,	  without	  accounting	  for	  the	  lag	  time	  after	  plating.	  The	  
best	  time	  to	  proceed	  with	  counting	  colonies	  can	  be	  determined	  by	  monitoring	  the	  cells	  in	  
the	  non-­‐irradiated	  control	  wells.	  	  
	   Once	  the	  colonies	  look	  ready	  for	  counting,	  the	  media	  from	  all	  the	  wells	  is	  aspirated.	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colonies.	  The	  colonies	  are	  allowed	  to	  sit	  in	  the	  formalin	  for	  approximately	  30	  minutes.	  
Afterwards	  the	  colonies	  are	  stained	  with	  1	  mL	  of	  0.01%	  (w/v)	  crystal	  violet	  and	  allowed	  to	  
sit	  for	  approximately	  60	  minutes.	  Then	  the	  excess	  is	  aspirated,	  and	  all	  the	  wells	  are	  allowed	  
to	  dry	  out	  completely.	  Once	  the	  plates	  are	  dry	  every	  well	  is	  individually	  imaged	  and	  each	  
image	  file	  is	  named	  appropriately	  to	  indicate	  the	  group	  that	  the	  imaged	  well	  belonged	  to.	  
Finally,	  the	  scorable	  cell	  colonies	  are	  counted	  and	  recorded.	  
	   The	  percent	  survival	  of	  the	  primary	  control	  was	  calculated	  for	  each	  experimental	  
group.	  First	  the	  plating	  efficiency	  was	  calculated	  to	  determine	  what	  percentage	  of	  cells	  that	  
were	  seeded	  would	  grow	  into	  colonies	  due	  to	  the	  plating	  process	  alone.	  This	  is	  coming	  
from	  the	  primary	  control	  group,	  without	  any	  experimental	  treatment,	  that	  just	  goes	  
through	  the	  process	  of	  the	  assay,	  e.g.	  lifting,	  diluting,	  replating.	  The	  plating	  efficiency	  is	  
calculated	  as	  (the	  #	  of	  colonies	  counted)/(the	  #	  of	  cells	  seeded).	  Once	  an	  average	  plating	  
efficiency	  is	  determined,	  the	  percent	  survival	  in	  an	  experimental	  group	  is	  calculated	  as	  
follows,	  (average	  #	  of	  colonies	  counted)/(#	  of	  cells	  seeded	  x	  average	  plating	  efficiency).	  
The	  standard	  error	  that	  was	  calculated	  for	  each	  group	  is	  represented	  as	  the	  standard	  
deviation	  divided	  by	  the	  square	  root	  of	  the	  sample	  size.	  For	  the	  normalization,	  these	  errors	  
were	  added	  in	  quadrature.	  A	  typical	  layout	  for	  this	  type	  assay	  produced	  12	  samples	  per	  
experimental	  treatment.	  
	   The	  complete	  experimental	  setup	  is	  rather	  lengthy.	  If	  there	  are	  no	  hindrances,	  then	  
a	  single	  data	  set	  can	  occupy	  from	  one	  week	  (MTT	  assay)	  up	  to	  three	  weeks	  (colony	  assay).	  
A	  generalized	  overview	  for	  the	  entire	  experimental	  design	  is	  shown	  in	  Fig.	  11.	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Fig.	  11	  A	  diagram	  of	  the	  main	  steps	  involved	  in	  the	  experimental	  design.	  This	  protocol	  
typically	  takes	  1-­‐3	  weeks	  to	  produce	  a	  single	  dataset.	  
	  	  
2.6	  Estimation	  of	  Nanoparticle	  Uptake	  
	   Gold	  type	  nanoparticles	  (GNPs)	  were	  brought	  into	  this	  study	  as	  a	  hopeful	  
benchmark	  for	  sensitization.	  GNPs	  have	  been	  shown	  to	  sensitize	  tumorous	  cells	  due	  in	  part	  
to	  their	  secondary	  electron	  emission	  properties	  [50-­‐55].	  1.9	  nm	  GNPs	  ordered	  from	  
AuroVist™	  Nanoprobes	  were	  used	  to	  investigate	  this	  effect,	  however	  the	  initial	  experiments	  
performed	  with	  the	  MTT	  assay	  quickly	  failed.	  The	  resulting	  absorbance	  values	  were	  
skewed	  due	  to	  the	  presence	  of	  the	  GNPs	  and	  their	  inherent	  metallic	  properties.	  There	  was	  
motivation	  to	  create	  an	  assay	  as	  a	  way	  to	  determine	  how	  much	  of	  gold-­‐type	  nanoparticles	  
were	  contributing	  to	  the	  absorbance	  values	  themselves.	  If	  an	  absorbance	  value	  can	  be	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be	  subtracted	  from	  the	  original	  readings	  to	  get	  more	  accurate	  absorbance	  values.	  This	  
would	  ultimately	  have	  the	  potential	  to	  indicate	  the	  amount	  of	  nanoparticles	  taken	  up	  by	  the	  
cells.	  
	   The	  experimental	  design	  is	  shown	  in	  Figure	  12.	  The	  alphanumerical	  labeling	  on	  the	  
48-­‐well	  microtiter	  plate	  was	  used	  to	  correspond	  to	  different	  treatments.	  It	  was	  decided	  
that	  each	  column	  on	  the	  plate	  (A	  through	  F)	  would	  contain	  all	  experimental	  groups	  needed	  
for	  one	  sample,	  this	  way	  the	  plate	  could	  produce	  8	  columns	  of	  samples	  for	  a	  desired	  
nanoparticle	  type	  or	  concentration.	  Row	  A	  contained	  media	  only,	  while	  row	  B	  contained	  
media	  plus	  nanoparticles.	  Row	  C	  contained	  media	  and	  cells.	  Rows	  D	  and	  E	  were	  treated	  the	  
same	  initially,	  both	  containing	  media,	  cells,	  and	  nanoparticles.	  Row	  F	  was	  intentionally	  left	  
empty	  in	  the	  beginning.	  Since	  irradiation	  was	  not	  required	  to	  do	  this	  study,	  it	  became	  a	  
fairly	  simple	  process	  occurring	  over	  the	  course	  of	  3	  days.	  
	   On	  the	  first	  day	  of	  this	  experiment,	  cells	  are	  plated	  using	  the	  same	  protocols	  as	  
before.	  Rows	  A	  and	  B	  receive	  200	  μL	  of	  media	  only,	  while	  rows	  C,	  D,	  and	  E	  are	  seeded	  with	  
200	  μL	  of	  suspended	  cells.	  The	  plates	  are	  then	  placed	  in	  the	  incubator	  at	  37°C	  (5%	  CO2)	  for	  
24	  hours,	  giving	  the	  cells	  plenty	  of	  time	  to	  adhere.	  On	  the	  second	  day,	  nanoparticles	  are	  
added	  in	  desired	  concentrations.	  Rows	  B,	  D,	  and	  E	  receive	  50	  μL	  of	  suspended	  
nanoparticles.	  Rows	  A	  and	  C	  are	  given	  50	  μL	  of	  media	  in	  order	  to	  ensure	  that	  all	  the	  wells	  
have	  an	  equal	  volume	  of	  250	  μL.	  The	  plates	  are	  then	  placed	  in	  the	  incubator	  at	  37°C	  (5%	  
CO2)	  for	  24	  hours,	  allowing	  plenty	  of	  time	  for	  the	  uptake	  of	  nanoparticles	  to	  take	  place.	  On	  
the	  third	  day,	  the	  media	  from	  row	  E	  is	  transferred	  to	  row	  F,	  which	  was	  strategically	  left	  
empty	  for	  this	  very	  step.	  Then	  an	  equal	  volume	  of	  fresh	  media	  (250	  μL)	  is	  added	  back	  to	  
	   53	  
row	  E.	  At	  this	  point	  the	  plates	  are	  ready	  to	  be	  scanned.	  The	  plates	  are	  scanned	  in	  the	  Tecan	  
plate	  reader,	  absorbance	  is	  measured	  at	  a	  wavelength	  of	  570	  nm,	  and	  the	  values	  are	  
exported	  to	  an	  Excel	  spreadsheet.	  
	  
Fig.	  12	  Experimental	  setup	  for	  the	  Absorption	  assay.	  
	   	  
	   This	  setup	  would	  determine	  any	  absorbance	  that	  comes	  from	  the	  nanoparticles,	  or	  
media	  and	  cells,	  or	  any	  combination	  thereof	  that	  contributes	  to	  the	  normal	  MTT	  assay	  
values.	  The	  nanoparticles	  that	  were	  taken	  up	  by	  the	  cells	  were	  defined	  as	  retained.	  
Unretained	  nanoparticles	  were	  defined	  as	  ones	  that	  were	  not	  taken	  up	  by	  the	  cells	  and	  left	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row	  B	  (media	  and	  nanoparticles)	  –	  row	  A	  (media	  only).	  	  The	  absorbance	  due	  to	  the	  
retained	  nanoparticles	  was	  calculated	  as	  row	  B	  (media	  and	  nanoparticles)	  –	  row	  F	  (media	  
and	  unretained	  nanoparticles).	  The	  absorbance	  from	  the	  unretained	  nanoparticles	  was	  
calculated	  as	  row	  F	  (media	  and	  unretained	  nanoparticles)	  -­‐	  row	  A	  (media	  only).	  	  
	   Manipulation	  with	  the	  remaining	  rows	  yielded	  several	  values	  of	  absorbance	  for	  
other	  combinations,	  some	  of	  which	  were	  negligible.	  Ratios	  of	  retained	  nanoparticles	  to	  
total	  nanoparticles	  were	  calculated.	  Averaging	  these	  ratios	  allowed	  for	  an	  estimation	  of	  the	  
percentage	  of	  nanoparticles	  taken	  up	  for	  a	  given	  concentration.	  The	  standard	  error	  that	  
was	  calculated	  for	  each	  group	  is	  represented	  as	  the	  standard	  deviation	  divided	  by	  the	  
square	  root	  of	  the	  sample	  size.	  These	  errors	  were	  added	  in	  quadrature.	  A	  typical	  layout	  for	  





Chapter	  3:	  Experimental	  Results	  
	  
3.1	  Survival	  Curve	  Results	  
Before	  treatment	  with	  nanoparticles	  began,	  cell	  survival	  curves	  were	  first	  determined.	  
These	  curves	  provided	  the	  targeted	  LD50	  value	  of	  proton	  irradiation	  used	  in	  experiments	  
with	  the	  corresponding	  cell	  line.	  Data	  was	  plotted	  on	  a	  semi-­‐logarithmic	  plot	  and	  fitted	  
using	  the	  linear-­‐quadratic	  model.	  This	  model	  is	  the	  accepted	  standard	  for	  plotting	  survival	  
rates	  in	  radiobiology	  [106-­‐108,	  110,	  111].	  The	  survival	  fraction	  is	  calculated	  as,	  
	   𝑆 = 𝑒! !"!!!! 	   (3.1)	  
where	  S	  represents	  the	  fraction	  of	  cells	  surviving,	  D	  represents	  the	  dose	  measured	  in	  Gy	  
while	  α	  and	  β	  are	  constants.	  	  For	  low	  LET	  radiation,	  these	  type	  curves	  generally	  have	  two	  
distinguishable	  segments,	  an	  initial	  linear	  portion	  that	  transitions	  into	  a	  subsequent	  
quadratic	  portion	  producing	  a	  shoulder	  region	  that	  connects	  the	  two.	  For	  higher	  LET	  
radiation	  such	  as	  proton	  radiation,	  the	  linear	  portion	  dominates	  and	  a	  straight	  fit	  is	  
observed.	  Therefore,	  the	  survival	  curves	  performed	  in	  this	  study	  were	  properly	  straight	  
since	  the	  quadratic	  portion	  of	  the	  fit	  was	  negligible	  in	  most	  cases.	  Previous	  research	  with	  
protons	  of	  comparable	  LET	  show	  this	  similar	  straight	  fit	  characteristic	  using	  hamster	  cells	  
[106].	  Figure	  13	  shows	  the	  184A1	  breast	  epithelial	  cell	  survival	  curve	  produced	  using	  the	  
MTT	  assay.	  Based	  on	  this	  curve,	  the	  LD50	  was	  found	  to	  be	  3.3	  Gy.	  Figures	  14	  and	  15	  show	  
the	  22RV1	  prostate	  carcinoma	  cell	  survival	  curves	  produced	  using	  the	  MTT	  and	  clonogenic	  
assays	  respectively.	  The	  MTT	  curve	  predicts	  the	  LD50	  value	  to	  be	  around	  55	  cGy,	  while	  the	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colony	  curve	  estimates	  it	  to	  be	  about	  75	  cGy.	  The	  decision	  was	  made	  to	  expose	  this	  cell	  line	  
at	  level	  higher	  than	  the	  LD50	  mark	  so	  that	  any	  drop	  in	  survival	  due	  to	  sensitization	  from	  an	  
experimental	  treatment	  would	  be	  most	  pronounced	  in	  a	  graphical	  representation.	  It	  was	  
decided	  that	  40	  cGy	  would	  be	  adequate	  for	  exposure.	  Figures	  16	  and	  17	  show	  the	  MCF7	  
breast	  carcinoma	  cell	  survival	  curves	  produced	  using	  the	  MTT	  and	  clonogenic	  assays	  
respectively.	  The	  MTT	  curve	  estimates	  the	  LD50	  value	  to	  be	  35	  cGy	  and	  the	  colony	  curve	  
shows	  a	  value	  closer	  to	  55	  cGy.	  Since	  these	  cells	  were	  so	  sensitive,	  a	  decision	  was	  made	  to	  
expose	  them	  at	  a	  level	  slightly	  higher	  than	  the	  LD50	  mark	  in	  order	  to	  increase	  the	  signal	  in	  
our	  assays.	  It	  was	  decided	  that	  30	  cGy	  would	  be	  sufficient.	  Although	  these	  survival	  curves	  
are	  not	  excessively	  compelling,	  they	  are	  sufficient	  in	  providing	  an	  estimated	  starting	  dose	  
for	  the	  purposes	  of	  this	  study.	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Fig.	  13	  Survival	  curve	  of	  the	  184A1	  breast	  epithelial	  cell	  line	  exposed	  to	  2	  MeV	  incident	  
protons.	  This	  data	  was	  collected	  using	  the	  MTT	  assay	  and	  was	  plotted	  on	  a	  semi-­‐log	  plot	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Fig.	  14	  Survival	  curve	  of	  the	  22RV1	  prostate	  carcinoma	  cell	  line	  exposed	  to	  2	  MeV	  incident	  
protons.	  This	  data	  was	  collected	  using	  the	  MTT	  assay	  and	  was	  plotted	  on	  a	  semi-­‐log	  plot	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Fig.	  15	  Survival	  curve	  of	  the	  22RV1	  prostate	  carcinoma	  cell	  line	  exposed	  to	  2	  MeV	  incident	  
protons.	  This	  data	  was	  collected	  using	  the	  clonogenic	  assay	  and	  was	  plotted	  on	  a	  semi-­‐log	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Fig.	  16	  Survival	  curve	  of	  the	  MCF7	  breast	  carcinoma	  cell	  line	  exposed	  to	  2	  MeV	  incident	  
protons.	  This	  data	  was	  collected	  using	  the	  MTT	  assay	  and	  was	  plotted	  on	  a	  semi-­‐log	  plot	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Fig.	  17	  Survival	  curve	  of	  the	  MCF7	  breast	  carcinoma	  cell	  line	  exposed	  to	  2	  MeV	  incident	  
protons.	  This	  data	  was	  collected	  using	  the	  clonogenic	  assay	  and	  was	  plotted	  on	  a	  semi-­‐log	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3.2	  CNP	  Results	  
	   Various	  types	  of	  CNPs	  were	  used	  throughout	  the	  course	  of	  this	  study.	  Some	  of	  them	  
were	  investigated	  in	  a	  parallel	  study[112]	  and	  other	  parameters	  of	  CNP	  treatment	  were	  
focused	  on	  in	  previous	  studies[113].	  Two	  of	  the	  CNP	  types	  will	  be	  discussed	  in	  detail	  
below.	  They	  are	  designated	  according	  to	  the	  label	  on	  their	  respective	  vials	  received	  from	  
UCF.	  Every	  CNP	  type	  and	  concentration	  that	  was	  examined	  had	  a	  corresponding	  non-­‐
irradiated	  control	  that	  was	  used	  to	  observe	  chemical	  toxicity.	  A	  non-­‐irradiated	  primary	  
control	  as	  well	  as	  an	  irradiated	  control	  with	  no	  additives	  was	  included	  in	  each	  experiment	  
to	  determine	  the	  radiation	  damage	  to	  untreated	  cells.	  These	  untreated	  controls	  are	  
typically	  labeled	  as	  having	  “0	  M”	  concentration	  of	  nanoparticles	  or	  as	  simply	  “No	  NP”.	  	  Each	  
set	  of	  data	  was	  analyzed	  two	  different	  ways	  for	  comparison.	  The	  first	  analysis	  compares	  all	  
experimental	  groups	  as	  a	  surviving	  percent	  of	  the	  primary	  non-­‐irradiated	  control.	  The	  data	  
are	  shown	  this	  way	  to	  document	  potential	  toxic	  effects	  (chemical	  toxicity)	  of	  the	  
nanoparticles.	  In	  the	  second	  analysis,	  the	  data	  points	  for	  each	  irradiated	  group	  are	  divided	  
by	  their	  respective	  non-­‐irradiated	  control	  to	  provide	  insight	  into	  any	  physical	  (radio-­‐
protective	  or	  enhancing)	  effects	  of	  the	  nanoparticles.	  Correct	  interpretation	  of	  any	  radio-­‐
effect	  of	  the	  nanoparticles	  requires	  subtraction	  of	  their	  inherent	  chemical	  effects.	  	  
184A1	  Results	  
	   Fig.	  18	  shows	  the	  effects	  of	  CNP	  type	  NH4	  screened	  in	  various	  concentrations	  
against	  the	  184A1	  breast	  epithelial	  cell	  line.	  The	  MTT	  assay	  was	  employed	  to	  survey	  the	  
different	  concentrations	  in	  order	  to	  expose	  any	  trends.	  The	  non-­‐irradiated	  controls	  show	  
evident	  signs	  of	  chemically	  toxic	  effects	  increasing	  with	  the	  NH4	  concentration,	  and	  the	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irradiated	  groups	  show	  some	  apparent	  sensitization	  effects	  at	  the	  higher	  concentrations.	  
The	  toxicity	  is	  statistically	  significant	  even	  at	  the	  low	  concentration	  of	  10	  nm,	  and	  becomes	  
highly	  significant	  at	  and	  above	  the	  100	  nm	  concentration.	  The	  net	  effect	  of	  the	  
nanoparticles	  yielded	  a	  significant	  26%	  drop	  and	  a	  highly	  significant	  36%	  drop	  in	  the	  100	  
nM	  and	  1	  μM	  groups	  respectively	  as	  compared	  to	  the	  irradiated	  0	  M	  group.	  Comparison	  of	  
each	  irradiated	  sample	  with	  its	  non-­‐irradiated	  control	  indicates	  that	  NH4	  produces	  a	  slight	  
physical	  protection	  with	  a	  6%	  increase	  at	  the	  10	  nM	  concentration	  in	  spite	  of	  toxicity	  when	  
compared	  to	  the	  untreated	  control	  group	  and	  increasing	  physical	  sensitization	  at	  the	  
100nM	  concentration	  with	  an	  11%	  drop	  and	  the	  1	  μM	  concentration	  with	  a	  26%	  drop.	  Only	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   Fig.	  19	  displays	  the	  CNP	  type	  NC	  investigated	  with	  various	  concentrations	  against	  
the	  184A1	  breast	  epithelial	  cell	  line	  using	  the	  MTT	  assay.	  The	  NC-­‐type	  nanoparticle	  shows	  
no	  signs	  of	  chemical	  toxicity	  among	  the	  non-­‐irradiated	  controls	  and	  possibly	  slight	  growth	  
promotion	  at	  the	  highest	  concentration.	  The	  irradiated	  groups	  reveal	  a	  significant	  net	  effect	  
is	  present	  at	  the	  10	  μM	  concentration	  producing	  a	  32%	  overall	  increase	  for	  this	  cell	  line.	  
Comparison	  of	  each	  irradiated	  sample	  with	  its	  non-­‐irradiated	  control	  indicates	  that	  
physical	  protection	  from	  the	  radiation	  is	  evident	  at	  the	  10	  μM	  concentration	  with	  an	  18%	  
increase	  when	  compared	  to	  the	  untreated	  control	  group,	  however	  this	  increase	  is	  not	  
statistically	  significant.	  It	  appears	  that	  at	  high	  concentrations	  of	  NC	  the	  chemical	  effects	  
start	  to	  interfere	  with	  any	  protective	  properties.	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   An	  experiment	  was	  performed	  in	  which	  the	  nanoparticles	  were	  added	  after	  
irradiation	  in	  order	  to	  see	  if	  the	  CNPs	  exhibited	  any	  radiomitigating	  properties	  as	  well.	  In	  
this	  experiment,	  184	  breast	  epithelial	  cells	  were	  exposed	  to	  a	  3.3	  Gy	  equivalent	  single	  dose	  
of	  proton	  radiation,	  NC	  and	  NH4	  were	  added	  post-­‐irradiation	  in	  10	  μM	  concentrations,	  and	  
the	  result	  was	  evaluated	  with	  the	  MTT	  assay	  shown	  in	  Fig.	  20.	  The	  results	  show	  no	  
significant	  chemical	  effect	  for	  NC	  but	  highly	  significant	  toxicity	  for	  NH4	  in	  the	  non-­‐
irradiated	  controls	  and	  the	  irradiated	  groups	  reveal	  no	  discerning	  effects.	  However,	  
comparison	  of	  each	  irradiated	  sample	  with	  its	  non-­‐irradiated	  control	  indicates	  that	  NH4	  
produced	  a	  higher	  percent	  of	  survival	  in	  spite	  of	  its	  own	  toxicity,	  yielding	  a	  statistically	  
significance	  increase	  of	  25%	  as	  compared	  to	  the	  untreated	  control	  group.	  NC	  had	  a	  slight	  
increase,	  but	  ultimately	  yielded	  no	  significant	  effect.	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22RV1	  Results	  
	   The	  results	  for	  a	  preliminary	  study	  performed	  with	  the	  22RV1	  prostate	  carcinoma	  
cell	  line	  are	  shown	  in	  Fig.	  21.	  In	  this	  experiment,	  cells	  were	  treated	  with	  NC	  and	  NH4	  
nanoparticles	  at	  1	  μM	  concentrations,	  exposed	  to	  a	  1	  Gy	  equivalent	  single	  dose	  of	  proton	  
radiation,	  and	  evaluated	  using	  the	  MTT	  assay.	  The	  non-­‐irradiated	  controls	  show	  no	  
significant	  chemical	  effects,	  while	  the	  irradiated	  groups	  appear	  to	  be	  showing	  some	  
sensitization	  properties.	  Although	  comparison	  of	  each	  irradiated	  sample	  with	  its	  non-­‐
irradiated	  control	  indicates	  that	  both	  NC	  and	  NH4	  treated	  cells	  show	  slight	  physical	  
sensitization	  to	  the	  radiation	  with	  a	  35%	  and	  23%	  decrease	  respectively	  when	  compared	  
to	  the	  untreated	  control	  group,	  it	  is	  not	  enough	  to	  be	  statistically	  significant.	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   Fig.	  22	  shows	  the	  effects	  of	  the	  CNP	  type	  NH4	  screened	  in	  various	  concentrations	  
with	  the	  22RV1	  prostate	  carcinoma	  cell	  line.	  Effects	  were	  evaluated	  using	  the	  MTT	  assay	  in	  
order	  to	  expose	  any	  trends.	  The	  non-­‐irradiated	  controls	  show	  obvious	  chemical	  toxicity	  
that	  increases	  with	  increasing	  NH4	  concentration.	  For	  the	  irradiated	  groups,	  every	  
concentration	  appears	  to	  be	  showing	  some	  degree	  of	  sensitizing	  properties.	  At	  the	  1	  μM	  
level,	  the	  net	  effect	  produced	  a	  highly	  statistically	  significant	  decrease	  of	  39%	  as	  compared	  
to	  the	  irradiated	  control	  group.	  Upon	  closer	  inspection	  however,	  comparison	  of	  each	  
irradiated	  sample	  with	  its	  non-­‐irradiated	  control	  demonstrates	  that	  because	  of	  the	  high	  
chemical	  toxicity,	  only	  the	  10	  nM	  concentration	  presents	  a	  physically	  sensitizing	  effect	  to	  
the	  radiation	  with	  a	  slight	  15%	  decrease	  as	  compared	  to	  the	  untreated	  control	  group,	  
however	  it	  is	  not	  enough	  to	  be	  significant.	  In	  fact,	  the	  higher	  concentrations	  present	  some	  
physical	  protection	  from	  the	  radiation	  in	  spite	  of	  their	  chemical	  toxicity,	  the	  greatest	  being	  
the	  10	  μM	  group	  with	  a	  highly	  significant	  75%	  increase	  when	  compared	  to	  the	  untreated	  
control	  group.	  It	  is	  believed	  that	  in	  this	  cell	  line	  NH4	  provides	  a	  chemically	  toxic	  effect	  that	  
is	  somewhat	  linear	  and	  a	  small	  non-­‐linear	  physical	  sensitization	  effect.	  As	  the	  
concentrations	  increase,	  this	  small	  sensitizing	  effect	  is	  outweighed	  by	  the	  toxicity	  and	  gives	  
way	  to	  more	  protective	  properties.	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   Fig.	  23	  displays	  the	  results	  for	  the	  CNP	  type	  NC	  investigated	  with	  various	  
concentrations	  against	  the	  22RV1	  prostate	  carcinoma	  cell	  line	  using	  the	  MTT	  assay.	  The	  
NC-­‐type	  nanoparticle	  shows	  obvious	  toxicity	  in	  the	  non-­‐irradiated	  controls,	  increasing	  with	  
concentration,	  while	  the	  irradiated	  groups	  exhibit	  some	  apparent	  protective	  properties.	  
The	  toxicity	  is	  statistically	  significant	  at	  the	  100	  nM	  and	  10	  μM	  concentrations.	  Comparison	  
of	  each	  irradiated	  sample	  with	  its	  non-­‐irradiated	  control	  shows	  no	  physical	  sensitization	  
whatsoever	  for	  NC,	  but	  rather	  physical	  protection	  from	  the	  radiation	  that	  increases	  with	  
concentration	  yielding	  a	  52%,	  80%,	  and	  108%	  increase	  for	  the	  100	  nM,	  1	  μM,	  and	  10	  μM	  
concentrations	  respectively	  as	  compared	  to	  the	  untreated	  control	  group.	  Only	  the	  100	  nM	  
and	  1	  μM	  concentrations	  are	  statistically	  significant	  however.	  It	  is	  believed	  that	  in	  this	  cell	  
line	  NC	  provides	  a	  protective	  effect	  with	  increasing	  concentration,	  while	  at	  the	  same	  time	  
presents	  a	  chemically	  toxic	  effect,	  and	  as	  the	  concentration	  increases,	  the	  toxic	  effects	  start	  
to	  overwhelm	  the	  protective	  properties.	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  Fig.	  24	  displays	  the	  data	  for	  NC	  at	  the	  1	  μM	  concentration	  and	  NH4	  at	  the	  10	  nM	  
concentration	  in	  the	  22RV1	  prostate	  carcinoma	  cell	  line	  evaluated	  with	  the	  clonogenic	  
assay.	  The	  results	  show	  no	  significant	  chemical	  effects	  in	  the	  non-­‐irradiated	  controls	  after	  
two	  weeks	  of	  growth	  with	  both	  nanoparticle	  types,	  and	  no	  evidence	  of	  sensitization	  or	  
protection	  in	  the	  irradiated	  groups	  either.	  Based	  on	  the	  clonogenic	  assay,	  there	  was	  no	  
visible	  effect	  with	  these	  type	  nanoparticles	  and	  their	  chosen	  concentrations	  in	  the	  22RV1	  
cell	  line,	  which	  conflicts	  with	  the	  results	  collected	  from	  the	  MTT	  assay.	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MCF7	  Results	  
	   Fig.	  25	  shows	  the	  CNP	  type	  NH4	  screened	  in	  various	  concentrations	  with	  the	  MCF7	  
breast	  carcinoma	  cell	  line.	  The	  MTT	  assay	  was	  used	  to	  survey	  the	  different	  concentrations	  
in	  order	  to	  expose	  any	  trends.	  The	  non-­‐irradiated	  controls	  show	  clear	  chemical	  toxicity	  that	  
increases	  quite	  linearly	  with	  increasing	  NH4	  concentration.	  The	  toxicity	  becomes	  highly	  
significant	  at	  and	  above	  the	  1	  μM	  concentration.	  For	  the	  irradiated	  groups,	  a	  net	  effect	  at	  
the	  10	  μM	  level	  produced	  a	  statistically	  significant	  decrease	  of	  42%	  as	  compared	  to	  the	  
irradiated	  0	  M	  group.	  Comparison	  of	  each	  irradiated	  sample	  with	  its	  non-­‐irradiated	  control	  
indicates	  some	  physical	  sensitization	  to	  the	  radiation	  at	  the	  100	  nM	  and	  10	  μM	  
concentrations.	  These	  concentrations	  show	  an	  18%	  and	  19%	  drop	  respectively	  when	  
compared	  to	  the	  untreated	  control	  group,	  however	  this	  drop	  is	  not	  statistically	  significant.	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   Fig.	  26	  displays	  the	  CNP	  type	  NC	  investigated	  with	  various	  concentrations	  with	  the	  
MCF7	  breast	  carcinoma	  cell	  line	  using	  the	  MTT	  assay.	  The	  NC-­‐type	  nanoparticles	  show	  
clear	  toxicity	  in	  the	  non-­‐irradiated	  controls	  that	  appears	  to	  increase	  quite	  linearly	  with	  
concentration.	  The	  toxicity	  is	  significant	  even	  at	  the	  low	  concentration	  of	  10	  nM	  and	  it	  
becomes	  highly	  significant	  at	  and	  above	  the	  100	  nM	  concentration.	  For	  the	  irradiated	  
groups,	  the	  net	  effect	  produced	  a	  highly	  significant	  38%	  drop,	  a	  significant	  25%	  drop,	  and	  a	  
highly	  significant	  31%	  drop	  in	  the	  100	  nM,	  1	  μM,	  and	  10	  μM	  groups	  respectively	  as	  
compared	  to	  the	  irradiated	  0	  M	  group.	  Comparison	  of	  each	  irradiated	  sample	  with	  its	  non-­‐
irradiated	  control	  implies	  there	  is	  significant	  physical	  sensitization	  to	  the	  radiation	  at	  the	  
100	  nM	  concentration	  yielding	  a	  27%	  decrease	  as	  compared	  to	  the	  untreated	  group.	  	  The	  
higher	  concentrations	  show	  an	  upward	  trend	  in	  spite	  of	  their	  increasing	  toxicity,	  which	  
suggests	  a	  protective	  attribute	  may	  be	  present	  at	  those	  concentrations	  as	  well.	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   Fig.	  27	  shows	  both	  NC	  and	  NH4	  at	  the	  100	  nM	  concentration	  in	  the	  MCF7	  breast	  
carcinoma	  cell	  line	  using	  the	  clonogenic	  assay.	  After	  two	  weeks	  of	  growth,	  the	  results	  show	  
the	  expected	  chemical	  toxicity	  in	  the	  non-­‐irradiated	  NC	  group	  and	  an	  unexpected	  chemical	  
growth	  promotion	  effect	  in	  the	  non-­‐irradiated	  NH4	  group,	  while	  both	  irradiated	  groups	  
appear	  to	  show	  some	  overall	  sensitization.	  The	  net	  effect	  for	  the	  NC	  group	  had	  a	  23%	  
decrease	  and	  the	  net	  effect	  for	  the	  NH4	  group	  had	  a	  42%	  decrease	  as	  compared	  to	  the	  
irradiated	  No	  NP	  group.	  Upon	  closer	  inspection,	  comparison	  of	  each	  irradiated	  sample	  with	  
its	  non-­‐irradiated	  control	  shows	  that	  once	  the	  chemical	  effects	  are	  factored	  out,	  only	  NH4	  
had	  a	  physically	  sensitizing	  effect	  to	  the	  radiation,	  resulting	  in	  a	  highly	  significant	  drop	  of	  
54%	  as	  compared	  to	  the	  untreated	  group.	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3.3	  Gold	  Nanoparticle	  Uptake	  Results	  
	   The	  results	  from	  an	  assay	  designed	  to	  look	  at	  uptake	  of	  nanoparticles,	  and	  outlined	  
in	  the	  methods	  section	  above,	  are	  shown	  in	  Figure	  28	  below.	  CNPs	  do	  not	  have	  any	  
measurable	  absorbance	  in	  the	  visible	  region,	  so	  gold	  nanoparticles,	  which	  absorb	  at	  570	  
nm,	  were	  used	  as	  a	  proxy	  to	  give	  a	  rough	  estimate	  of	  particle	  uptake.	  GNPs	  of	  various	  
concentrations	  were	  used	  with	  the	  22RV1	  prostate	  carcinoma	  cell	  line	  and	  evaluated	  for	  
their	  uptake	  into	  the	  cells.	  The	  values	  displayed	  in	  Figure	  28	  below	  represent	  a	  ratio	  of	  the	  
retained	  nanoparticles	  within	  the	  cell	  to	  the	  total	  nanoparticles	  that	  were	  added	  to	  the	  
culture	  media	  as	  a	  way	  to	  demonstrate	  how	  much	  of	  the	  GNPs	  are	  taken	  up	  by	  the	  cells.	  For	  
the	  100	  nM,	  1	  μM,	  and	  10	  μM	  concentrations,	  34%,	  52%,	  and	  82%	  of	  the	  GNPs	  initially	  
added	  were	  found	  to	  be	  retained	  in	  the	  cells	  respectively.	  Using	  a	  projected	  fit,	  the	  10	  nM	  
concentration	  was	  extrapolated	  to	  be	  around	  8%.	  Making	  the	  broad	  assumption	  that	  the	  
rates	  of	  uptake	  between	  the	  two	  different	  types	  of	  particles	  are	  roughly	  the	  same,	  this	  
simple	  assay	  may	  provide	  information	  on	  the	  uptake	  of	  the	  CNPs.
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Fig.	  28	  Gold	  nanoparticles	  (GNPs)	  added	  to	  the	  22RV1	  prostate	  carcinoma	  cell	  line	  are	  
assessed	  for	  their	  retention	  in	  the	  cells	  using	  an	  absorption	  assay.	  Data	  are	  expressed	  as	  
percentages	  of	  the	  initial	  nanoparticle	  treatment	  added	  to	  cells	  (mean	  ±	  standard	  error).	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   Using	  the	  calculated	  absorbance	  value	  for	  the	  retained	  GNPs	  found	  in	  the	  absorption	  
assay,	  a	  previous	  data	  set	  was	  corrected	  by	  subtracting	  this	  from	  the	  original	  values	  to	  
obtain	  a	  more	  accurate	  representation	  of	  metabolically-­‐determined	  cell	  viability.	  In	  this	  
experiment,	  GNPs	  were	  added	  to	  the	  184A1	  breast	  epithelial	  cell	  line	  in	  10	  μM	  
concentrations	  and	  then	  the	  cells	  were	  exposed	  to	  a	  2	  Gy	  equivalent	  single	  dose	  of	  proton	  
radiation	  and	  assessed	  using	  the	  MTT	  assay.	  The	  results	  are	  shown	  in	  Figure	  29	  below.	  The	  
results	  present	  a	  chemical	  growth	  promotion	  effect	  in	  the	  non-­‐irradiated	  gold	  (Au)	  control	  
with	  no	  apparent	  effect	  in	  the	  irradiated	  group.	  However,	  this	  growth	  promotion	  effect	  is	  
not	  statistically	  significant.	  Comparison	  of	  each	  irradiated	  sample	  with	  its	  non-­‐irradiated	  
control	  indicates	  that	  there	  was	  enough	  physical	  sensitization	  to	  the	  radiation	  in	  spite	  of	  
the	  growth	  promotion	  to	  yield	  an	  apparent	  29%	  decrease	  when	  compared	  with	  the	  
untreated	  control	  group;	  however,	  this	  decrease	  was	  not	  statistically	  significant.	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   Figure	  30	  shows	  GNPs	  investigated	  in	  various	  concentrations	  with	  the	  MCF7	  breast	  
carcinoma	  cell	  line	  and	  the	  22RV1	  prostate	  carcinoma	  cell	  line.	  The	  MCF7	  cells	  and	  the	  
22RV1	  cells	  were	  exposed	  to	  25	  cGy	  and	  30	  cGy	  equivalent	  single	  dose	  of	  proton	  radiation	  
respectively	  and	  evaluated	  using	  the	  clonogenic	  assay.	  There	  is	  clear	  evidence	  of	  severe	  
chemical	  toxicity	  in	  the	  non-­‐irradiated	  controls	  after	  2	  weeks	  of	  growth	  and	  no	  clear	  effect	  
in	  the	  surviving	  irradiated	  groups.	  The	  toxicity	  in	  all	  of	  the	  non-­‐irradiated	  treated	  controls	  
for	  both	  cell	  lines	  is	  highly	  statistically	  significant.	  With	  so	  much	  chemical	  toxicity	  in	  these	  
cell	  lines,	  the	  data	  is	  undoubtedly	  skewed	  making	  it	  difficult	  to	  determine	  anything	  
meaningful	  with	  regards	  to	  any	  protective	  or	  sensitive	  effects.	  	  
	  









































































































































































































































































































































































































































































































































































































































































































Chapter	  4:	  Discussion	  
	  
	   The	  aims	  of	  this	  research	  were	  1)	  to	  determine	  if	  CNP	  treatment	  would	  offer	  a	  
protective	  effect	  to	  non-­‐malignant	  cells	  and	  2)	  to	  demonstrate	  that	  CNPs	  would	  enhance	  
the	  rate	  of	  killing	  in	  tumor	  cells	  as	  well	  when	  exposed	  to	  particle	  radiation.	  The	  effects	  of	  
CNPs	  on	  cells	  exposed	  to	  x-­‐rays	  has	  been	  investigated	  in	  some	  detail	  [17,	  64-­‐67],	  but	  
similar	  research	  using	  proton	  irradiation	  has	  not	  been	  carried	  out	  to	  any	  extent.	  	  
4.1	  Cell	  Survival	  Data	  
	   Initially,	  cell	  survival	  curves	  were	  measured	  to	  find	  an	  estimated	  dose	  of	  
administration	  that	  was	  close	  to	  the	  true	  LD50	  level.	  	  A	  table	  summarizing	  these	  LD50	  
values	  and	  the	  chosen	  dose	  values	  is	  shown	  in	  Figure	  31	  below.	  	  
	  
Fig.	  31	  A	  table	  summary	  of	  the	  predicted	  LD50	  values	  from	  the	  cell	  survival	  curves	  with	  the	  
chosen	  dose	  values.	  
	  
	   This	  was	  performed	  somewhat	  successfully	  in	  all	  three	  cell	  lines	  because	  the	  cell	  
killing	  did	  in	  fact	  increase	  with	  increasing	  dose	  and	  could	  be	  plotted	  using	  the	  linear-­‐
quadratic	  model.	  However,	  the	  MTT	  assay	  only	  indicates	  metabolic	  activity,	  so	  there	  is	  the	  
possibility	  that	  it	  can	  misrepresent	  the	  genuine	  cell	  survivability.	  Cell	  survival	  is	  truly	  
Cell$Survival$Curves$ 184A1$ 22RV1$ MCF7$
MTT#LD50#Values# #3.3#Gy# 55#cGy# 35#cGy#
Colony#LD50#Values# ~# 75#cGy# 55#cGy#
Chosen#Dose#Values# 3.3#Gy# 40#cGy# 30#cGy#
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indicated	  by	  cell	  proliferation.	  There	  could	  be	  metabolically	  active	  cells	  being	  picked	  up	  by	  
the	  MTT	  assay	  that	  would	  have	  little	  to	  no	  proliferation.	  Plating	  variability	  is	  a	  concern	  as	  
well.	  The	  number	  of	  cells	  that	  were	  plated	  can	  be	  determined	  and	  controlled	  to	  be	  
consistent	  among	  wells,	  but	  true	  cell	  proliferation	  is	  a	  stochastic	  process	  and	  is	  responsible	  
for	  a	  large	  portion	  of	  the	  error	  in	  these	  experiments.	  Also,	  the	  cell	  populations	  in	  this	  study	  
were	  asynchronous.	  Cells	  in	  this	  population	  that	  were	  in	  the	  part	  of	  the	  cell	  cycle	  preparing	  
for	  mitosis	  or	  undergoing	  mitosis	  were	  particularly	  vulnerable	  to	  damage.	  Research	  has	  
shown	  that	  these	  mitotic	  cells	  are	  more	  radiosensitive	  than	  the	  non-­‐mitotic	  cells	  [114].	  
This	  can	  result	  in	  two	  distinct	  populations,	  which	  could	  yield	  a	  survival	  curve	  that	  initially	  
drops	  at	  lower	  doses	  due	  to	  the	  killing	  of	  the	  more	  radiosensitive	  population	  and	  then	  
gradually	  falls	  at	  the	  higher	  doses	  due	  to	  the	  remaining	  radioresistant	  population	  [115].	  
Although	  the	  linear-­‐quadratic	  model	  is	  well	  used	  in	  the	  field	  of	  radiobiology,	  it	  does	  not	  
incorporate	  DNA	  repair	  and	  the	  transformation	  of	  cells	  due	  to	  radiation	  exposure.	  The	  
transformation	  process	  could	  include	  mutated	  cells	  that	  are	  permitted	  to	  grow	  beyond	  the	  
set	  restrictions	  of	  the	  remaining	  population,	  allowing	  them	  to	  find	  new	  forms	  of	  survival.	  
Contemporary	  models	  include	  these	  factors	  using	  a	  combination	  of	  linear,	  quadratic,	  and	  
higher	  order	  terms	  and	  could	  provide	  a	  superior	  fit	  for	  high	  LET	  radiation	  [116,	  117].	  
4.2	  CNP	  Data	  
	   Various	  types	  and	  concentrations	  of	  CNPs	  were	  then	  tested	  for	  their	  protective	  and	  
sensitizing	  properties	  in	  all	  three	  cell	  lines	  with	  some	  success.	  The	  experimental	  results	  
from	  that	  testing	  are	  summarized	  below	  in	  Figure	  32.	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Fig.	  32	  A	  table	  summary	  of	  the	  experimental	  results	  showing	  only	  significant	  effects.	  
(*=Significant,	  **=Highly	  Significant)	  
	  
	   Both	  NC	  and	  NH4	  CNPs	  were	  examined	  in	  the	  184A1	  breast	  epithelial	  cell	  line	  to	  
determine	  if	  any	  protective	  effects	  would	  emerge.	  MTT	  results	  indicate	  the	  best	  candidate	  
for	  radioprotection	  to	  be	  NC	  at	  the	  10	  μM	  concentration,	  which	  yielded	  a	  net	  effect	  increase	  
of	  32%	  compared	  to	  the	  untreated	  group.	  Another	  MTT	  experiment	  in	  which	  nanoparticles	  
were	  added	  post-­‐irradiation	  indicates	  that	  NH4	  was	  the	  superior	  radiomitigator,	  with	  a	  
25%	  increase	  compared	  to	  the	  untreated	  group	  in	  the	  secondary	  interpretive	  step.	  The	  
radioprotective	  characteristics	  of	  CNPs	  stem	  from	  their	  ability	  to	  act	  as	  free	  radical	  
Physical)Effects) 184A1) 22RV1) MCF7)
MTT#Assay#(NH4)# Sensi1za1on#*# None# None#
MTT#Assay#(NC)# None# Protec1on#*# Sensi1za1on#*#
Colony#Assay#(NH4)# ~# None# Sensi1za1on#**#
Colony#Assay#(NC)# ~# None# None#
Net)Effects) 184A1) 22RV1) MCF7)
MTT#Assay#(NH4)# Decrease#(36%)#**# Decrease#(39%)#**# Decrease#(42%)#*#
MTT#Assay#(NC)# Increase#(32%)#*# None# Decrease#(38%)#**#
Colony#Assay#(NH4)# ~# None# Decrease#(42%)#*#
Colony#Assay#(NC)# ~# None# None#
Chemical)Effects) 184A1) 22RV1) MCF7)
MTT#Assay#(NH4)# Toxicity#**# Toxicity#**# Toxicity#**#
MTT#Assay#(NC)# None# Toxicity#**# Toxicity#**#
Colony#Assay#(NH4)# ~# None# None#
Colony#Assay#(NC)# ~# None# None#
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scavengers	  with	  indirect	  damage	  caused	  by	  the	  radiolysis	  process.	  This	  was	  shown	  with	  
previous	  research	  using	  the	  high	  indirect	  damage	  produced	  by	  x-­‐rays	  to	  produce	  high	  cell	  
survival	  rates	  [17].	  By	  contrast,	  with	  charged	  particle	  radiation	  there	  is	  more	  direct	  DNA	  
damage	  sustained	  and	  less	  indirect	  damage	  to	  the	  DNA	  from	  free	  radicals.	  This	  may	  explain	  
why	  the	  CNPs	  were	  not	  as	  effective	  in	  the	  cells	  against	  proton	  radiation	  as	  they	  were	  with	  
x-­‐ray	  exposure.	  
	   For	  the	  22RV1	  prostate	  carcinoma	  cell	  line,	  the	  preliminary	  MTT	  study	  using	  CNPs	  
at	  a	  concentration	  of	  1	  μM	  showed	  some	  promise	  of	  sensitization	  for	  both	  CNPs.	  However,	  
further	  experiments	  revealed	  NH4	  to	  be	  the	  best	  candidate	  with	  a	  net	  effect	  drop	  of	  39%	  at	  
the	  1	  μM	  level	  when	  compared	  to	  the	  untreated	  group.	  Also,	  it	  is	  worth	  mentioning	  that	  the	  
lowest	  concentration	  of	  NH4	  indicated	  slight	  physical	  sensitization	  when	  the	  data	  were	  
analyzed	  to	  compare	  each	  irradiated	  sample	  with	  its	  corresponding	  non-­‐irradiated	  control	  
(15%,	  not	  statistically	  significant)	  and	  showed	  no	  significant	  chemical	  effects	  in	  the	  non-­‐
irradiated	  control.	  On	  the	  other	  hand,	  the	  results	  from	  the	  colony	  assay	  demonstrated	  that	  
there	  were	  no	  significant	  effects	  for	  either	  CNP	  in	  the	  long	  term.	  	  
	   In	  the	  MCF7	  breast	  carcinoma	  cell	  line	  counterpart,	  both	  NC	  and	  NH4	  showed	  
promising	  physical	  sensitization	  using	  the	  MTT	  assay.	  NH4	  showed	  a	  significant	  42%	  drop	  
in	  the	  10	  μM	  group	  when	  compared	  to	  the	  untreated	  group	  and	  the	  implied	  physical	  
sensitization	  from	  the	  interpretive	  step	  yielded	  a	  19%	  drop	  also.	  NC	  revealed	  a	  net	  effect	  
that	  produced	  a	  highly	  significant	  38%	  drop	  in	  the	  100	  nM	  group	  when	  compared	  to	  the	  
untreated	  group	  and	  the	  implied	  physical	  sensitization	  from	  the	  secondary	  step	  yielded	  a	  
significant	  27%	  drop	  as	  well.	  The	  results	  from	  the	  colony	  assay	  were	  not	  perfectly	  aligned,	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but	  did	  show	  NH4	  as	  the	  best	  emerging	  candidate	  with	  a	  significant	  net	  effect	  decrease	  of	  
42%	  when	  compared	  to	  the	  untreated	  group	  and	  an	  implied	  physical	  sensitization	  from	  the	  
secondary	  step	  of	  54%.	  The	  chemical	  effects	  that	  were	  detected	  in	  this	  study	  were	  a	  main	  
issue	  of	  concern.	  The	  CNPs	  toxicity	  has	  shown	  conflicting	  results	  in	  previous	  studies	  
suggesting	  that	  the	  chemical	  effects	  come	  from	  their	  ability	  to	  transition	  between	  the	  two	  
valence	  states	  and	  increase	  the	  presence	  of	  oxygen	  vacancies	  [118].	  This	  could	  explain	  
some	  of	  the	  inconsistencies	  observed.	  
4.3	  GNP	  Data	  
	   Gold	  type	  nanoparticles	  have	  been	  shown	  to	  sensitize	  tumorous	  cells	  due	  in	  part	  to	  
their	  secondary	  electron	  emission	  properties	  [50-­‐55].	  	  It	  has	  been	  shown	  that	  their	  main	  
pathway	  into	  the	  cell	  is	  due	  to	  RME	  (receptor-­‐mediated	  endocytosis)	  with	  dependency	  on	  
conditions	  such	  as	  size,	  shape,	  surface	  charge,	  and	  added	  functional	  groups	  [119].	  One	  
study	  using	  protein-­‐coated	  GNPs	  found	  that,	  more	  specifically,	  the	  clathrin-­‐dependent	  
endocytosis	  pathway	  is	  the	  main	  transport	  system	  into	  the	  cells	  [120].	  GNPs	  were	  brought	  
into	  this	  research	  as	  a	  hopeful	  benchmark	  study	  under	  the	  assumption	  that	  they	  could	  be	  
used	  as	  a	  sensitization	  standard	  for	  comparison	  purposes.	  	  The	  percent	  of	  GNPs	  absorbed	  
by	  the	  cells	  after	  initial	  administration	  was	  successfully	  determined	  in	  the	  22RV1	  prostate	  
tumor	  cell	  line	  using	  a	  novel	  absorption	  assay.	  These	  percentages	  could	  be	  used	  as	  a	  
reference	  to	  describe	  CNP	  absorption	  since	  they	  are	  comparable	  in	  size.	  	  An	  MTT	  assay	  
with	  GNPs	  show	  some	  sensitizing	  properties	  in	  the	  non-­‐malignant	  184A1	  cell	  line.	  It	  was	  
expected	  that	  this	  sensitization	  characteristic	  of	  gold	  would	  show	  up	  in	  the	  malignant	  cell	  
lines	  of	  MCF7	  and	  22RV1	  as	  well.	  However,	  that	  characteristic	  was	  not	  discovered.	  Colony	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data	  reveals	  tremendous	  toxicity	  and	  therefore	  no	  sensitizing	  effect	  was	  found	  in	  the	  
irradiated	  groups.	  It	  is	  possible	  that	  their	  cytotoxicity	  is	  just	  too	  overwhelming	  to	  interpret	  
anything	  meaningful	  with	  these	  cell	  lines.	  GNPs	  have	  been	  shown	  to	  have	  a	  significant	  cell-­‐
line	  dependent	  correlation	  between	  uptake	  and	  toxicity	  [51].	  These	  surprising	  results	  
could	  also	  be	  explained	  by	  the	  effects	  of	  GNPs	  with	  proton	  radiation.	  One	  study	  used	  Monte	  
Carlo	  simulations	  to	  compare	  the	  effects	  of	  GNPs	  between	  photon	  radiation	  and	  proton	  
radiation,	  and	  found	  that	  since	  most	  of	  the	  absorbed	  GNPs	  remained	  tied	  up	  in	  lysosomes	  
and	  don't	  enter	  the	  nucleus,	  the	  secondary	  electrons	  generated	  from	  proton	  radiation	  may	  
not	  have	  sufficient	  range	  to	  reach	  the	  nucleus	  and	  cause	  damage,	  whereas	  the	  secondary	  
electrons	  generated	  by	  the	  photon	  radiation	  did	  have	  sufficient	  range	  [52].	  
	   The	  results	  presented	  here	  demonstrate	  the	  properties	  of	  cerium	  oxide	  
nanoparticles	  to	  provide	  sensitization	  for	  malignant	  breast	  cells.	  There	  were	  some	  
indications	  of	  protective	  properties	  in	  the	  nonmalignant	  breast	  cells	  as	  well	  and	  further	  
investigation	  could	  confirm	  these	  effects.	  These	  properties	  are	  determined	  by	  the	  surface	  
valence	  states	  of	  the	  nanoparticles,	  which	  are	  dependent	  on	  the	  microenvironment	  of	  the	  
CNP	  itself.	  Some	  potential	  applications	  of	  CNPs	  include	  the	  enhancement	  of	  ion	  beam	  
therapy	  in	  the	  treatment	  of	  some	  cancers	  and	  possible	  protection	  from	  terrestrial	  and	  
space	  radiation.	  
4.4	  Future	  Directions	  
	   The	  potential	  for	  cerium	  oxide	  nanoparticles	  to	  be	  used	  as	  a	  radiosensitizer	  has	  
been	  shown	  previously	  [64,	  65,	  67].	  All	  of	  the	  investigations	  involving	  these	  
radiosensitizers	  and	  their	  effect	  on	  cancer	  cells	  have	  been	  examined	  with	  x-­‐ray	  exposure,	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so	  there	  was	  no	  experimental	  data	  showing	  results	  with	  regards	  to	  charged	  particle	  
radiation.	  It	  was	  the	  goal	  of	  this	  research	  to	  start	  that	  investigation	  into	  CNPs	  sensitization	  
effect	  of	  cancer	  cells	  and	  their	  protective	  effect	  on	  normal	  cells	  with	  the	  use	  of	  proton	  
radiation.	  The	  fluctuating	  chemical	  toxicity	  in	  this	  study	  was	  a	  cause	  for	  concern.	  However,	  
recent	  adaptations	  of	  CNPs	  involve	  using	  a	  polyethylene	  glycol	  cap	  to	  enhance	  stability,	  
reduce	  cytotoxicity,	  and	  improve	  biological	  properties	  [121].	  This	  variant	  could	  be	  
investigated	  with	  future	  experiments.	  This	  initial	  investigation	  contained	  many	  
experimental	  variables,	  including	  a	  wide	  range	  of	  CNP	  concentrations	  that	  the	  cells	  were	  
exposed	  to.	  Additional	  studies	  could	  investigate	  promising	  CNPs	  between	  these	  established	  
concentrations	  in	  order	  locate	  a	  value	  that	  would	  minimize	  the	  chemical	  effects	  and	  
maximize	  the	  physical	  effects	  while	  improving	  the	  dose	  reduction	  factor.	  With	  the	  ability	  of	  
ECU’s	  Pelletron	  Accelerator,	  further	  investigation	  could	  implement	  various	  ion	  beams	  to	  
study	  the	  CNPs	  effect	  against	  heavier	  charged	  particles.	  The	  titanium	  foil	  used	  at	  the	  end	  of	  
the	  beamline	  was	  sufficient	  for	  maintaining	  vacuum	  and	  providing	  minimal	  loss	  in	  beam	  
energy,	  but	  a	  thinner	  exit	  window	  could	  decrease	  the	  energy	  loss	  even	  further	  and	  is	  
feasible	  with	  stronger	  metal	  alloys	  like	  Havar	  foil,	  which	  has	  been	  used	  in	  other	  similar	  
experimental	  setups	  [122].	  This	  could	  facilitate	  the	  use	  of	  lower	  energy	  ion	  beams	  on	  CNP	  
treated	  cells	  to	  assess	  their	  effects	  at	  higher	  LET	  values.	  In	  vivo	  studies	  with	  mice	  may	  
present	  a	  better	  understanding	  of	  the	  complete	  whole	  body	  effects	  of	  implementing	  the	  
CNPs.	  There	  are	  extensive	  nanoparticle	  candidates	  available	  for	  optional	  avenues	  in	  future	  
research.	  Using	  the	  current	  setup,	  it	  would	  be	  valuable	  to	  assess	  the	  effects	  of	  different	  
nanoparticle	  types	  used	  to	  treat	  tumor	  cells.	  This	  could	  be	  beneficial	  in	  the	  upcoming	  area	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